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Abstract
The “big data” challenge is changing the way we acquire, store, analyse, and draw conclusions from
data. How we effectively and efficiently “mine” the data from possibly multiple sources and extract
useful information is a critical question. Increasing research attention has been drawn to healthcare
data mining, with an ultimate goal to improve the quality of care. The human body is complex and
so too the data collected in treating it. Data noise that is often introduced via the collection process
makes building Data Mining models a challenging task.
This thesis focuses on the classification tasks of mining healthcare data, with the goal of improving
the effectiveness of health risk prediction. In particular, we developed algorithms to address issues
identified from real healthcare data, such as feature extraction, heterogeneity, label uncertainty, and
large unlabeled data.
The three main contributions of this research are as follows. First, we developed a new health
index called Personal Health Index (PHI) that scores a person’s health status based on the examination
records of a given population. Second, we identified the key characteristics of the real datasets and
issues that were associated with the data. Third, we developed classification algorithms to cope with
those issues, particularly, the label uncertainty and large unlabeled data issues.
This research takes one step forward towards scoring personal health based on mining increas-
ingly large health records. Particularly, it pioneers exploring the mining of GHE data and tackles the
associated challenges. It is our anticipation that in the near future, more robust data-mining-based
health scoring systems will be available for healthcare professionals to understand people’s health
status and thus improve the quality of care.
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Chapter 1
Introduction
In early 2015, the United States government announced an initiative for precision medicine [30],
which referred to prevention and treatment strategies that took individual variability into account.
This was not a single event but signified an emerging trend of improving personalised healthcare by
utilising increasingly large amounts of available health data as well as powerful computational tools
for data analysis.
The field of research that explores Data Mining technology to meet the needs of the healthcare
industry has a variety of names, such as Healthcare Data Mining, Data Mining in Healthcare [74],
Medical Data Mining [110, 28], and Clinical Data Mining [62], depending on the emphasis of the
types of data and applications. In general, digitally stored healthcare data, possibly collected from
multiple information sources and in different forms, is called Electronic Health Record (EHR). An
EHR covers a wide range of information about an individual, such as but not limited to, person demo-
graphics, observations, laboratory tests, diagnostic reports, treatments, therapies, prescriptions, and
allergies [36]. By monitoring a person’s EHRs over time, the longitudinal fluctuation of his or her
health status can be tracked. Therefore the longitudinal EHRs of individuals provide a rich reposi-
tory for healthcare data analysis and predictive modeling. However, developing effective models for
healthcare applications is very challenging, especially due to noise, incompleteness, heterogeneity,
and longitudinality of the real data.
In this chapter, we briefly introduce the motivation, background, challenges and goals, and our
main contributions in healthcare data mining.
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1.1 Motivation
Most developed countries have experienced dramatic growth in elderly populations from the begin-
ning of this century. In recent years, this, together with the rising cost of healthcare has created an
urgent need for improving predictions and efficient treatment. For example, the U.S. government
spent $414.3 billion in elderly health care in 2011, $100 billion higher than the inflation-adjusted
costs of 2001 [89]. Many developed countries, such as Australia [1], United Kingdom [9], and Tai-
wan [55], provide periodic General Health Examinations (GHEs) to their senior citizens as an integral
part of preventive healthcare for the elderly. These programs enable continuous and comprehensive
recording of a person’s health status, as well as the tracking of his/her health changes. However, it
is always a difficult task for healthcare professionals to provide an overall report on personal health
after a comprehensive medical check-up has been performed because of hundreds of the parameters
available to be considered.
One particular focus of preventive healthcare is risk assessment. The goal is to identify individu-
als at risk for further investigation or early treatment and intervention. Traditionally, risk assessments
have been conducted manually by clinical professionals based on their expertise. These manual as-
sessments have been constrained by the capacity of the human brain to process information within a
limited time during the period of an appointment with a patient.
Many risk-scoring systems have been developed in the field of medicine to assist clinical decision-
making, for example, the APACHE, SAPS, and MPM for Intensive Care Unit patients [42]. As a
general practice in medical research, these methods have been defined based on factors selected with
expert knowledge and validated via population-based studies [128].
With the advances in computing technology and the availability of EHRs, an increasing number
of data mining and machine learning applications have been developed to support healthcare decision
making [37, 134]. In recent years methods for clinical risk classification have been developed [122,
121, 127, 88, 92]. However, most existing studies have their focus on EHRs. GHE records and the
unique challenges they pose have not yet been well explored. This gap has driven our research to
advance risk prediction models for GHE records.
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1.2 Background
To enable better understanding of our research and the challenges behind it, we introduce our datasets
and discuss their characteristics below.
1.2.1 Datasets
The key datasets of this thesis contain a General Health Examination (GHE) dataset and a Cause
of Death (COD) dataset. These datasets have been linked together via the common attribute Person
ID, revealing the association between examination results and main Cause of Death. Records of
participants with non-health-related COD were excluded in our preprocessing because the goal of our
research is to build effective risk prediction models.
General Health Examination (GHE) Data
GHE is a de-identified dataset for elderly people with all private information, such as names, contact
details, and birth dates removed. The dataset has 230 attributes, containing 262,424 check-ups of
102,258 participants aged 65 or above, collected during a period of six years, from 2005 to 2010. The
overall ratio of male to female participants is 1.03:1. Each de-identified GHE record is represented
by a Person ID and the examination results from a wide range of lab tests, physical examinations,
the Brief Symptom Rating Scale (BSRS) mental health assessment, the Short Portable Mental Status
Questionnaire (SPMSQ) cognitive function assessment, and (de-identified) demographics. Personal
health-related habits are also available, such as exercise, eating, drinking, and smoking habits. Key
attributes are listed in Table 1.1.
The data was collected during a standard annual health examination program for elderly people,
run by the Taipei City Government, Taiwan (R.O.C.). Participants voluntarily took part in the pro-
gram, and were encouraged to visit on a yearly basis. Data related to individual identification was
removed before the dataset acquisition. The acquisition and processing of the data was approved by
the Institutional Review Board (IRB) of the Taipei City Hospital, Taiwan (R.O.C.).
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TABLE 1.1: Selected GHE attributes by categories
Type Category Attribute (example)
Patient Profile
Demographics age, marital status, gender, education level, residential suburb
Habits reasons-for-taking-medicine, smoking, drinking, exercise, drink-milk, eat-
vegetable, clean-teeth
Lab Tests
Biochemical glu-ac, total cholesterol (tcho), thyroglobulin (tg), got, gpt, albumin (alb),
thyroid stimulating hormone (tsh)
Blood red blood cell, white blood cell, plate, hematocrit (hct), mean corpuscu-
lar volume (mcv), mean corpuscular hemoglobin (mch), alpha-fetoprotein
(afp), hemoglobin (hb)
Urine outlook, ph, protein, sugar, blood, red blood cell, white blood cell, pus cell,
epithelium cell, casts
Other faecal occult blood test (fobt)
Examinations
Physical weight, height, waist, systolic blood pressure, diastolic blood pressure,
pulse rate
External neck, chest, heart, breast, abdomen, back, rectum, limbs, prostate
Other X-ray, EKG, cervical smear, abdominal ultrasound
Mental Health BSRS 5 questions regarding nervousness, anger, depression, comparison with
others, and sleep
Cognitive Function SPMSQ 10 questions, e.g., current date, day of the week, where the person is situ-
ated, home address, age, year of birth, etc.
Cause of Death (COD) Data
The GHE dataset was linked to the Taiwan National Death Registry system using participants’ iden-
tification numbers and then encrypted to provide de-identified secondary data maintained by the De-
partment of Health of the Taipei City Government. We called this linked subset of data the Cause
of Death (COD) dataset. The main causes of death were encoded with the WHO International Clas-
sification of Diseases [2], a standard medical ontology for disease classification. CODs were coded
with the 9th ICD revision (ICD-9) from years 2005 to 2008 and the 10th ICD revision (ICD-10) from
years 2009 to 2010. There were in total 522 ICD-9 codes and 925 ICD-10 codes used in the COD
dataset. Attributes available from the linked information included a 3-4 digit ICD code for main cause
of death and time of death in the format of month and year.
For the purpose of risk prediction, we only included those who passed away within three years of
their last examination record. This left us with 7,569 participants with COD codes, which was about
7.4% of our dataset.
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FIGURE 1.1: An example of a person’s health examination records.
1.2.2 Data Characteristics
We have identified key characteristics of the above described GHE and COD datasets. These charac-
teristics not only constitute the key challenges of our research, but also differentiate our work from
existing studies on mining EHRs. Some characteristics have been associated with the GHE records;
others were identified from the COD labels. In the following, we will discuss them in detail.
GHE Characteristics
To illustrate the key characteristics of GHE data, an example of the record sequence of a GHE par-
ticipant is given in Figure 1.1. The horizontal axis is the time in years and the vertical axis indicates
examination items of various categories. Cells in black mark the items whose results were abnormal
at that year. The gaps between cells for a given year, say 2005, were the items not tested during that
year; the years with no records, say 2007 and 2008, were the years that the person did not take the
examination.
Three characteristics have been identified from our GHE dataset, as listed below.
• Infrequency: As GHE was offered on a yearly basis, the record sequences were infrequent,
compared with time-series healthcare data, such as ECG and body movements collected from
wearable sensor devices [88, 103, 109]. Time-series data from wearable devices were often
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collected in the frequency of Hertz, so the problem was often how to extract more compact data
representation to save computational cost [129]. By contrast, the infrequency of GHE data gave
us relatively short sequences with various lengths.
• Incompleteness: Due to the voluntary nature of GHE, a person might have only taken a couple
of non-consecutive GHEs in his or her lifetime. Therefore, the record sequences were incom-
plete along the timeline. Also, the health examination program may have changed over time so
the examination items covered in the program would also have changed accordingly. As a re-
sult, GHE records were incomplete as well in the sense of missing observations of examination
items in certain years.
• Sparsity: Clinical judgements were often based on abnormal findings such as observed symp-
toms, signs, or lab test results. From the perspective of abnormalities, GHE records, especially
that of lab tests and mental health assessments, were likely to be sparse, because the majority
of the results would have been likely to be normal.
• Heterogeneity: As shown in Table 1.1, GHE records were composed of results from a wide
range of lab tests, physical examinations, cognitive and mental assessments, and personal habits
(e.g., exercise and diet habits). They were often collected from different sources, using differ-
ent types of machines and measurements, focusing on different parts of the human body, and
reflecting different aspects of a person’s health status. Therefore, this heterogeneity of GHE
records should be respected and considered in the analysis and modeling of the data.
The above four characteristics of GHE data differentiate our work from two strains of traditional
classification problems. On one hand, our problem was different from the traditional point-based
classification, where an example is viewed as a point in a multi-dimensional space, represented as a
feature vector. After all, in our case a person may have more than one record. On the other hand, our
problem was also different from the traditional time-series classification problem, which focused on
the handling of high frequency series, such as ECG series [129, 103, 109], because of the infrequency
and incompleteness of our GHE records.
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Label Characteristics
In addition to the characteristics of the GHE dataset, there are two characteristics associated with the
COD labels that have been identified, namely label uncertainty and large unlabeled data, as illustrated
below.
• Label Uncertainty: In a clinical context, a label can be a recorded illness, death, or a prescrip-
tion of medicine. Label uncertainty has commonly been found in clinical judgments due to
expert subjectivity and inadequate information [104]. Often, it is handled as noise, so the task
has been to detect and correct such mislabeling [87, 107, 45]. However, in the case of multiple,
non-exclusive medical conditions [82], such as comorbidity, it makes more sense to treat labels
with degrees of certainty rather than forcing them to belong to one “true” class, because there
is no such thing as a single true class in this kind of scenario.
This issue applies to COD labels, because a participant might have comorbidity but only the
main cause of death was recorded. Therefore, the recorded COD labels should be treated as
with a degree of certainty. Note that if multiple labels are given at a point in time, it becomes a
multi-label learning problem that predicts multiple labels at a time, which is a different problem
from what we are dealing with here.
• Large Unlabeled Data: About 92.6% of the 102,258 participants in the GHE dataset did not
have a COD label. The semantics of such “alive” cases varied from generally healthy to very ill,
and anywhere in between. This implies that there is no ground truth available for the “healthy”
cases, which meant we were dealing with large unlabeled data. In fact, the unlabeled data rate
in our dataset was 92.6%.
These two characteristics associated with the COD labels constitute the key challenges of our re-
search, which will be further elaborated in Section 1.3.
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Differences from EHRs
Although GHE records, being also digitally stored health data, can be seen as a subset of EHRs, it is
worth noting their differences. EHRs have been mainly collected for patient management and subse-
quent administrative use. The focus has been on the clinical care for a specific problem of a patient.
Therefore the recorded data, at any given point in time, also had its focus on the specific problem.
After all, given limited medical resources, a doctor would only order tests that are considered as
necessary for further understanding an illness of a patient or confirming a diagnosis for the patient.
By contrast, GHE records often covered a rather comprehensive set of general health measures
for regular surveillance and preventive purposes [86]. A large number measures were collected at a
point in time during the examination program in a systematic way. This provides a comprehensive
coverage of a person’s health status for the point in time that was not available in the general EHRs.
In this study, our research only focuses on GHE records. However, it can be foreseen that powerful
clinical decision support systems will be available in the future when GHE data and EHR patient data
can be collected, linked, and considered together.
1.2.3 Formal Definition
After introducing the GHE dataset and discussing its key characteristics, now we can formally define
GHE records of a person. A person may have participated in a GHE program for many but possibly
non-consecutive years. We call the sequence of a person’s GHE records their GHE Record Sequence.
Formally, it can be defined as follows.
Definition 1.1 (GHE Record Sequence). A participant pi’s GHE records are represented as a time-
stamped sequence ri of length ni, where each element at position j is a tuple (tij, vij), where vij is
a d-dimensional mixed variable type vector that stores the GHE results of year tij . Mathematically,
ri = ((ti1, vi1), (ti2, vi2), ..., (tini , vini)). In addition, we use ri(m) to denote pi’s records upto the m
th
record, i.e., ri(m) = ((ti1, vi1), (ti2, vi2), ..., (tim, vim)).
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1.3 Research Challenges
The problem that we address in this thesis is a classification problem on healthcare data. Most work
including the one in this thesis focused on health risk prediction based on mining large healthcare
data collected from multiple sources, namely the linked GHE and COD datasets. We sometimes refer
to the problem as a health score prediction problem in this study, particularly as the Personal Health
Index prediction problem, where the score is defined on health risks. The problem is formulated as a
classification-based risk prediction problem using the linked main Cause of Death (COD) information
as label.
In addition, we also explored another data source, namely a medical literature database. In this
classification task, instead of predicting health risks, we rank drugs based on medical literature for
drug recommendations.
The key challenges of the research presented in this thesis are closely related to the data charac-
teristics identified in Section 1.2.2, which are listed as follows.
• Feature Extraction: GHE record sequences are infrequent, incomplete, sparse, and heteroge-
neous, as discussed in Section 1.2.2. How to pre-process and extract features from GHE record
sequences, in order to capture enough information for effectively representing the health status
of a person is a challenge. The considerations include how do we model the time aspect of the
GHE record sequences that demonstrates the changes of a person’s health over time. This issue
is mainly handled in Chapter 3.
• Heterogeneity: GHE generally covers a wide range of health assessments, including lab tests,
physical examinations, cognitive and mental assessments, as well as personal habits such as
exercise and diet habits. These assessments may be recorded in possibly different measure-
ments, scales, and data formats, focusing on different parts of the body. Designing a model that
is capable of capturing and harnessing this heterogeneity is challenging. This issue is mainly
handled in Chapter 5.
• Label Uncertainty: Due to the possible comorbidity and the fact that only one cause would
be chosen by an authorized person (e.g., a general practitioner) as the main cause of death in
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documenting a death certificate, there is always a certain degree of uncertainty pertaining to
these COD labels. Therefore, the challenge becomes how do we build a model that is able to
handle label uncertainty. This challenge is handled in Chapter 4.
• Large Unlabeled Data: Most GHE participants are without a COD label. In fact, these people
account for 92.6% of the GHE participants in our dataset (see Section 1.2.2). However, the
health status of these unlabeled GHE participants can vary from healthy to ill. In addition, there
is no “ground truth” available for the healthy examples. Therefore, we were left with a machine
learning problem with large unlabeled data and with the absence of negative (healthy) cases.
Learning a model that is capable of dealing with this issue is very challenging. This problem
will be handled in Chapter 5.
1.4 Research Goals
This section discusses the research goals of this thesis. At the highest level, our aim was to build
effective classification models for healthcare decision support. An overview of our research goals can
be found in Figure 1.2.
The main focus is on Classification-based Health Risk / Score Prediction. This is to enable iden-
tification of individuals at risk based on their health examination records. The predicted outputs are
expressed as scores, either in terms of risk scores or health scores that we called Personal Health
Index (PHI). We first defined as a complement probability of overall health risk and later extended it
to a vector of scores representing the health risks in disease categories.
The second focus is on Classification-based Recommendation. This research was to explore addi-
tional data sources with the hope to integrate them into our classification-based health risk prediction
framework and improve the overall performance. This exploration, particularly in medical literature
data, led to a classification-based recommendation problem that is addressed as our fourth goal.
A summary of the goals of our research is listed as follows.
• The primary goal is to design and implement a framework for classification-based prediction as
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FIGURE 1.2: Overview of the research goals.
the first step of the research. Particularly, our approach needed to consider the special charac-
teristics of GHE record sequences, namely irregularity, incompleteness, sparsity, as well as the
time aspect or the longitudinality for effective feature extraction and data modeling.
• The second goal was to incorporate the handling of label uncertainty into the classification
framework, extending it from an overall prediction to a disease-level prediction. To tackle the
label uncertainty issue, we focused on a soft-label learning approach that learns soft labels as
health scores for disease categories.
• The third goal was to design a framework that was capable of dealing with large amount of un-
labeled data and in the absence of the ground truth examples for “healthy” cases. We proposed a
graph-based semi-supervised learning approach to tackle the problem. In order to demonstrate
the stability of our proposed algorithm, we evaluate the performance of the proposed algorithm,
using both synthetic and real datasets.
• The last goal was to explore medical literature as an additional data source for literature-based
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decision support. Particularly, we approached a drug recommendation problem by adapting a
graph-based and ranking-based classification algorithm.
1.5 Main Contributions
The main contributions of this thesis are described as follows.
1.5.1 A Classification-based Framework for Personal Health Index Prediction
As the first step of our research, the purpose of this work was to develop and implement a basic
framework for health risk prediction. Since the highest health risk is health-related death, we explored
the health-related main Cause of Death (COD) information linked to the GHE participants as the
labels. Particularly, the COD information was used as binary labels (alive/deceased) and the output
predicted score for an individual can be viewed as based on the mortality risk.
In this work, we introduced a health scoring system called Personal Health Index (PHI) to quantify
the overall health status of a person. PHI is defined as a complement probability, i.e., 1 − mortality
risk. The issues we encountered in this study include the following
• Data pre-processing. This is a known challenge for medical data modeling. As reported by
Esfandiary et al. in [37], pre-processing takes about 60% to 90% of the project effort in prac-
tice. Key data pre-processing issues encountered in this work included data cleaning, natural
language processing on the data collected from free-text entries, sparse data modeling, and
missing value handling.
• Feature extraction. As described in Section 1.2.1, our GHE dataset had 230 attributes and con-
tained a mixture of numerical, categorical and free-text data types. How we extracted features
that preserved the relevant information for effective prediction is critical.
• Classification and model selection. The selection of classification models is very often problem-
specific and data-driven. The state-of-the-art data mining algorithms were considered and ex-
perimentally evaluated for the effectiveness of our framework.
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• Class imbalance problem. As mentioned earlier in Section 1.2.1, about 7.4% of the partici-
pants in GHE dataset were deceased. In other words, the positive class only accounts for 7.4%
cases, which makes the class distribution imbalanced.
Our main contributions are listed as follows.
• This work pioneered in applying data mining techniques to the problem of predicting personal
health scores based on health examination records of the whole population. Particularly, we
defined the Personal Health Index (PHI) to quantify health status and develop a classification-
based prediction framework to effectively infer a person’s PHI.
• For feature extraction, we proposed representation extraction strategies to handle the longitudi-
nality of the GHE record sequences.
• The effectiveness and stability of the proposed framework have been demonstrated by experi-
ments conducted based on the real health datasets, namely the GHE and COD datasets.
1.5.2 A Soft-label Learning Approach for Disease-level Personal Health Index
Prediction with Label Uncertainty
The aim of this work is to extend the basic framework of Personal Health Index (PHI) prediction from
predicting an overall health score to a disease-level prediction. In the basic framework, PHI represents
a score of overall health, calculated based on the mortality risk. In this work, PHI was redefined as a
vector of scores, each reflecting the health risk in a particular disease category. We made use of the
disease-level cause of death information from the COD dataset as the classification label.
However, the disease-level COD code suffers from the label uncertainty issue. A person only has
one COD code recorded as the main cause of death, but he might suffer from comorbidity. Therefore,
his or her COD code only captures part of the real health status. Given such incomplete information,
we addressed this as a label uncertainty issue and proposed a soft-label learning solution for the
problem. The accurate soft labels are interpreted as health scores.
The main contributions of this work are summarized as follows.
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• We extended the concept of PHI from a single overall health score based on all-cause mortality
to a vector of scores, each reflecting personal health risk in a disease category.
• Rather than treating labels as 100% certain, as in our previous work, we designed a soft-label
learning solution to handle label uncertainty.
• Experimentally we demonstrated the effectiveness of our method based on a large GHE dataset
of 262,424 records from 102,258 participants.
1.5.3 A Graph-based Classification Approach for Health Risk Prediction with
Large Unlabeled Data
Large unlabeled data is a reality of most healthcare applications. As pointed out in Section 1.2.1,
about 92.6% of the participants in our GHE dataset have no COD labels. In addition, their health
conditions can vary from generally healthy to very ill. In order to handle this issue of large unlabeled
data with no ground truth for negative (healthy) cases, we proposed a graph-based semi-supervised
learning approach called SHG-Health that learns soft labels as health scores for a range of disease
categories. The proposed algorithm is able to predict an additional “unknown” class to handle the
unlabeled cases.
In comparison, our previous work summarised in Section 1.5.2 did not consider the large unla-
beled data issue; rather, it randomly selected the unlabeled data the same size as the labeled data
and treated these “alive” cases as the “negative” examples. The proposed model in this work takes
the reality of large unlabeled data into account. It is able to handle heterogeneity of GHE records
by exploring the graph structure. A additional mechanism of learning an extra class is designed for
handling the unlabeled data.
The main contributions of this work are listed as follows:
• We presented the SHG-Health algorithm to handle a challenging multi-class classification prob-
lem with substantial unlabeled cases which may or may not belong to the known classes. This
work pioneered risk prediction based on healthcare data in the presence of large unlabeled data.
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• A novel graph extraction mechanism was introduced for handling heterogeneity found in lon-
gitudinal health examination records.
• The proposed graph-based semi-supervised learning algorithm SHG-Health combines the ad-
vantages from heterogeneous graph learning and class discovery. It demonstrated significant
performance gain on a large and comprehensive real health examination dataset as well as syn-
thetic datasets.
1.5.4 A Graph-based Ranking Approach for Literature-based Drug Recom-
mendations
Finally, we diverted ourselves from the GHE and COD datasets to explore another type of data source,
namely medical literature, with the hope to eventually integrate the findings into our risk prediction
framework. In this study, we approached an anti-hypertensive drug recommendation problem based
on the MEDLINE bibliographic database and its linked medical ontology MeSH.
The drug recommendation problem was formulated as a ranking-based classification problem. We
adapted our previous work MedRank [20], a graph-based ranking algorithm to solve the problem. To
evaluate the system recommended list, we designed a questionnaire to collect drug usage preference
from clinical professionals. This work was carried out in my 3-month internship at the Hunan Re-
search Center for Hypertension, Third Xiangya Hospital, Central South University, Changsha, China.
1.6 Thesis Organization
The remainder of the thesis is organized as follows. In Chapter 2, we review the literature related to
the research topics in this thesis. Chapter 3 focuses on a classification-based framework for Personal
Health Index (PHI) prediction. We introduce the concept of PHI and present a group of representation
extraction strategies for effective classification. In Chapter 4, we extend PHI to a vector of disease-
level health scores, and propose a soft-label learning approach to handle label uncertainty. Chapter
5 focuses on the issue of large unlabeled data commonly found in real-world health datasets and
presents a graph-based semi-supervised learning method as our solution to the problem. In Chapter 6
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we adapted a ranking-based classification algorithm to solve a literature-based drug recommendation
problem. Finally, the conclusions and future research directions are summarized in Chapter 7.
Chapter 2
Literature Review on Healthcare Data
Analysis and Mining
The advances in storage technology, computational power, and the gradual digitalization of healthcare
data in the past ten years have led to a new era of healthcare data analysis and modeling [35]. What
was once done manually and limited by human capacity can now be assisted by computers on a scale
that could hardly have been imagined in the past.
With the overwhelmingly large healthcare data available, the urgent question now is how to design
smarter tools to explore, analyze, utilize, and harness the data. In board terms, the field of research
is called Health Informatics, which is a discipline that combines information science and computer
science within the realm of healthcare with a goal to ultimately improve the quality of care [56].
According to the review of Herland et al. [56], Health Informatics can be categorized into five sub-
fields, namely Bioinformatics, Neuroinformatics, Clinical Informatics, Public Health Informatics, and
Transitional BioInformatics (TBI), based on the level of human existence that they are focusing on
(i.e., molecular-level, tissue-level, patient-level, population-level, and combined-level, respectively).
Across these sub-fields, data mining is a key tool for big data analytics. In fact, an increasing number
of data mining applications has been developed to improve healthcare services over the years [34,
110, 62].
In this thesis, we target classification problems in healthcare applications, particularly classification-
based health prediction problems. We will first review the traditional approaches for health scoring
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and health data analytics in medical research. Secondly, we will review studies on mining health-
care data especially with a focus on classification. Particularly, we will look at existing work on
classification-based risk prediction. In addition, we will review the existing studies related to the
challenges identified from our real datasets in Section 1.3, especially, label uncertainty, and large
unlabeled data. Finally, we will look at existing work on mining medical literature.
2.1 Traditional Approaches in Medical Research
In medical research, such as biomedicine and public health, it is common to have repeated observa-
tions of multiple outcomes [14], resulting in multivariate longitudinal data. Statistical methods are
often used for data analysis. The goal for such analysis is to model the multiple responses over time
and understand their relationships, especially the correlation. In this section, we will review the ex-
isting studies in this domain from two aspects. First, we will summarize existing medical studies on
health examination data and their approaches. Secondly, we will discuss studies on health scoring
systems developed for clinical decision support.
2.1.1 Data Analytics on Health Examination Data
Medical studies on health examination data analysis are mainly found in the field of epidemiology,
particularly in population-based analysis on prevalence and risk factors [108, 41, 126]. A general
practice is to formulate a hypothesis on a set of risk factors and validate the hypothesis using a
version of regression analysis. The goal of learning model parameters, in this case, is not so much
for predicting future cases, as for factor-importance weighting, which is then validated via statistical
testing [41, 126].
The datasets in use are mostly based on sampled participants of health examination surveys; there-
fore, often the longitudinal records of participants are not available. For example, the U.S. National
Health and Nutrition Examination Survey (NHANES) datasets [8] are probably the most popular and
highly researched health examination datasets. NHANES datasets contain samples about 5,000 par-
ticipants each year in the U.S. based on certain subgroup proportions predetermined by the authorities.
At the time of writing, there were 1,860,000 retrieved publications on NHANES data analysis from
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Google Scholar, mostly in the fields of Medicine or Public Health.
The strength of NHANES datasets lies in its data collection method that gives representative
samples of the whole population or certain targeted groups. However, except for a small number
of follow-ups on certain test items, a person’s longitudinal records are generally not available from
the NHANES datasets. There are also private datasets with traceable patient history, but they are
generally difficult to obtain. For example, a dataset of 462,293 participants was studied for risk factor
analysis for all-cause mortality attributable to kidney disease [126].
2.1.2 Health Scoring Systems
In medical practices, it is important to quantify a person’s health status into numerical values from
observations. Methods that are developed to calculate and attribute a score to an aspect of health to
support assessments are generally known as health index or scoring systems. This section will review
existing studies in these categories.
Health index
Health indices provide numerical expressions of a person’s health status [69]. Such indices may
be expressed as a single value aggregated from a list of factors [135, 93], or in terms of a profile of
interrelated scores [40]. Generally, “Health Index” refers to a numerical indication of health of a given
population, while “Health Status Index” denotes a set of measurements for members of a population
[105].
For example, the Charlson’s Index [19] was introduced in 1987 for classifying clinical comor-
bidity in order to assess whether a patient will live long enough to benefit from a specific screening
measure or medical intervention. Later, Deyo et al. [33] adapted the Charlson’s Index for ICD-9-CM
administrative databases. Newman et al. [93] designed a physiological index for comorbidity based
on five noninvasive tests across the full range of values. These type of indices are typically defined
based on factors manually selected by experts and validated by epidemiological studies.
For indices designed for personal health status, Yi et al. [135] developed a bio-mark based system
to grade personal health status. They also call it personal health index. The index is calculated based
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on a linear combination of four indices, whose weights are determined by expert knowledge. These
four indices are cardiovascular index, stress index, obesity index, and management index. However,
their approach has the following three disadvantages: First, they do not consider the multiple years
of data available for the same person, which shows a continuous development of a personal health
status. Second, they do not take the ultimate health risk (i.e., the death) of a person into account for
predicting a person’s health status. Third, their computation does not rank an individual’s situation
against the whole population.
To sum up, the existing approaches of health index computations are purely based on expert
knowledge and thus only consider a limited set of factors.
Scoring Systems
Prognostication has long been a common practice for physicians. In order to minimize human sub-
jectivity and errors due to optimism and fatigue, different scoring systems have been introduced. For
example, Greenberg et al. [50] proposed a prognostic scoring system for myelodysplastic syndromes,
known as the International Prognostic Scoring System (IPSS). Many scoring systems that quantify the
severity of illness were introduced over the years for places such as Intensive Care Unit (ICU) [43]
and palliative care [49]. The most commonly used ones in such intensive care are the Acute Physi-
ology Age and Chronic Health Evaluation (APACHE), Simplified Acute Physiology Score (SAPS),
and Mortality Prediction Model (MPM). They have been improved over recent years and the latest
versions are APACHE IV [145], SAPS 3 [91], and MPM III [58].
Studies have been conducted to compare the discrimination and calibration of these scoring sys-
tems in terms of predicting ICU mortality, as well as the effect of the presence and absence of certain
variables. For example, Keegan et al. [71] showed that APACHE III and APACHE IV had better dis-
crimination than SAPS 3 and MPM III. Moreover, the addition of the resuscitation status variable that
is exclusive to MPM III did not improve the prediction of APACHE III, APACHE IV, and SAPS 3.
Generally, these methods are defined based on factors selected with expert knowledge and validated
via population-based studies [128]. However, as discussed earlier, it becomes problematic when the
dimensionality increases and the longitudinal aspect is involved.
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Roothman et al. filed a patent for a monitoring system that generates patient health score for hos-
pital patient care and management [111]; however, the underlying scoring mechanism is unknown.
Online scoring systems for personal health management have also been gaining in popularity in re-
cent years. For example, Nuffield Health Score [5] computes user’s health score online based on a
set of predefined measurements uploaded from mobile sensor devices. However, neither of them is
adaptive to the rapid growth of information, for example collected from health examination records
or electronic health records, as the number of factors to be considered in these cases would also grow
rapidly.
2.2 Data Mining on Healthcare Data
Data mining is a practice that extracts useful and interesting information from big data [117]. Key
Data Mining tasks include classification, regression, clustering, association rule mining and hybrid
approach.
With the increasing amount of healthcare data stored digitally over the years, more and more
researchers in the Data Mining community have devoted themselves to developing applications to
improve healthcare services. According to the classification of Esfandiary et al. in their comprehen-
sive review [37], data mining applications in medicine can be viewed in terms of six key activities in
medicine, namely, screening, diagnosis, treatment, prognosis, monitoring, and management.
In this section, we will focus our discussions on the classification task. We will start with a
general review of existing studies on healthcare data classification, followed by a closer look at the
literature on health risk prediction. Then we will survey two special issues in the literature, namely
label uncertainty and large unlabeled data.
2.2.1 Classification on Healthcare Data
Classification is a data mining task of assigning objects to one of several predefined categories [117].
In the literature of healthcare data mining, one strain is in morbidity prediction where the emphasis is
on predicting specific diseases. Cancer has been the most researched illness amongst all [37, 125, 102,
137]. Studies on other diseases have also been reported, such as but not limited to, diabetes [92, 113],
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heart failure [106], mental health problems like depression or suicide [120, 121], or special diseases
[96, 90]. Another strain focuses on mortality/survivability prediction, for example, on Intensive Care
Unit (ICU) patients [6] or cancer patients [73].
In this section, we will review some representative methods in recent years, with a focus on studies
on classification-based risk prediction. We will leave the existing works with a special focus on label
uncertainty and unlabeled data issues to Section 2.2.2 and Section 2.2.3
Wei et al. [125] proposed an ensemble method for cancer prediction on gene expression data.
They adapted a hypercuboid learning approach based on rough set theory to provide more inter-
pretable prediction. Nguyen et al. [96] introduced a classification method for heparin induced throm-
bocytopenia. Their model took into account the soft-label information that reflected how strongly the
human expert felt about the original class labels. Specifically, they added an auxiliary term for soft
label in the standard SVM formulation and showed improved performance on their dataset.
Pan et al. [102] proposed a boosting approach for graph-based cost-sensitive classification called
CogBoost to handle network data such as chemical compounds for anti-cancer activity prediction.
Their iterative algorithm involves a depth-first search optimal subgraph exploration step, a risk min-
imization step with linear programming, and a graph weight update step. CogBoost outperforms the
other boosting-based and SVM-based methods empirically.
To deal with multivariate time series that are often found in ECG and ICU data, Ghalwash et al.
[47] formulated a logistic-loss constraint optimization problem for interpretable multivariate pattern
extraction. The effectiveness of the proposed method has been demonstrated in terms of classification
performance based on an ECG dataset and two blood gene expression datasets, although the datasets
they used were rather small (i.e., 17, 20, 448 patients respectively).
In the following subsection, we will review classification-based studies that have a focus on pre-
dicting health risks.
Classification for Health Risk Prediction
Most existing studies on medical risk classification are based on patient EHRs. Commonly studied
diseases for screening data classification are cancer, Alzheimer’s disease, and diabetes [37]. Mohktar
et al. introduced an exacerbation risk prediction system for chronic obstructive pulmonary disease
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using home tele-health measurement data [90]. They used a classic classifier, namely the CART
algorithm.
Liu et al. [85] introduced a scoring system for cardiac arrest prediction based on the ECG sig-
nals, vital signs, and demographic data of 1,386 critically ill patients. The initial score was calculated
based on geometric distances between the query point and the cluster centres of the positive class
and the negative class respectively. Then the score was updated using SVM-based classification and
neighborhood checking. They also adopted feature extraction methods, such as Principal Component
Analysis (PCA), Kernel PCA, and Linear Discriminant Analysis (LDA). Simon et al. [113] devel-
oped a method for early diabetes mellitus risk assessment based on association rule summarisation
techniques. The area they targeted was the large amount of rules returned by traditional association
rule mining algorithms.
To handle data sparsity, Wang et al. [122] proposed a multilinear sparse logistic regression model
for clinical risk prediction to handle especially EHRs that come in a tensor form, for example, the
functional MRI (fMRI) data. The method has been verified using a synthetic dataset and a fMRI
dataset of 1,005 Alzheimer’s Disease patients. Their proposed algorithm was shown to outperform
classical classifiers such as Nearest Neighbor and Support Vector Machines, as well as other forms of
Logistic Regression models such as sparse logistic regression. However, their method assumes that
the input tensors have a fixed dimensionality, so it is not directly applicable to longitudinal EHRs with
various lengths.
Qian et al. [106] designed a relative-similarity-based method for active patient risk prediction.
They proposed a linear neighborhood propagation framework to learn a patient similarity matrix,
based on which patient risk can be predicted. Their method was evaluated using UCI breast cancer and
diabetes data, MRI data of patients with Alzheimers disease, as well as real EHR data of congestive
heart failure patients.
In terms of how the longitudinal aspect of EHR is handled, Neuvirth et al. [92] proposed a frame-
work for personalized care management based on time-series data from diabetes patients. They com-
pared classical models for binary classification, using different feature selection and extraction strate-
gies. Time-series is merged along time axis by computing the mean on each feature.
Wiens et al. [127] introduced a novel concept of risk time-series. In their two-stage SVM-based
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framework for hospital acquired Clostridium difficile risk classification, multi-dimensional time-series
patient records are reduced to one-dimensional risk time-series, from which summary statistics were
extracted for classification. Tran et al. [120] introduced a suicide risk classification framework based
on a dataset of 10,000 patients dataset. They modelled longitudinal patient records as an image, and
applied a bank of one-side filters for temporal feature extraction.
Summary
As a summary, most existing works use patient data, especially patient EHRs, collected from people
who were already suspected or diagnosed to be sick [121, 90, 75, 96, 102, 141]. However, mining
general health examination data is an area that has not yet been well-explored, except a few studies
on risk prediction such as the chronic disease early warning system proposed in [64].
In [64], Jen et al. extracted 53 features from medical examination data and case histories of 2,724
cases of six chronic diseases. They proposed a classification framework based on Linear Discriminant
Analysis (LDA) for feature extraction and the K Nearest Neighbor (KNN) classifier.
However, their methodology was not comparable, because they only used positive cases (patients
of pre-selected 6 diseases) and did not concern the potentially harder-to-handle negative cases (i.e.,
those without disease labels). Their goal was a multi-class classification problem, namely to correctly
classify the disease that a given patient would have amongst six possible diseases.
2.2.2 Classification with Label Uncertainty
Label uncertainty is often treated as label noise in the literature. Label noise may come from four
different sources according to the survey of Frenay et al. [44], namely human expert inadequacy
(e.g., unknown testing result), non-expert unreliability (e.g., crowd sourcing), human subjectivity
(e.g., medical judgement), and data encoding or communication problems.
In the medical domain, key sources of label noise are expert subjectivity and inadequate informa-
tion in clinical judgments such as diagnosis [104]. Such noise is usually regarded as mislabeling to
be detected and corrected [87, 107, 45]. For example, Garca-Zattera et al. employed binary Markov
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models to estimate misclassification parameters for dental research [45]. Rantalainen et al. intro-
duced a Bayesian approach to detect control subjects who might be actually the undiagnosed cases
in a case-control study [107]. The underlying assumption of these approaches was that ground-truth
labels exist and those labels are certain, so the task was to detect and correct mislabeling caused by
human inadequacy.
However, uncertainty may come from multiple, non-exclusive medical conditions [82]. For exam-
ple, health-related death can be caused by the complications of several co-existing diseases, and the
identified main cause of death (COD) may only explain the death to a certain degree. In such cases,
rather than identifying “mislabeled” cases, it does make sense to allow labels to have a certain degree
of certainties.
Lin et al. introduced a decision support system for lower back pain diagnosis that expresses
diagnostic uncertainty using verbal probability estimation; however, their system was highly expert-
dependent as the knowledge base relied on experts to maintain the updates. Recently Nguyen et
al. [96] introduced a learning approach that considered the auxiliary soft-label information collected
from human experts to quantify label uncertainty. They included an additional term in the original
SVM formulation to define the loss of not respecting the orders induced by the auxiliary subjective
probabilities. Their proposed methods showed better performance than methods that did not consider
the auxiliary soft-label information.
In the field of Computer Vision, Yi et al. [133] introduced a soft-label learning approach for
complex event detection on Web videos. In the context of event detection on videos, there were often
only a few positive instances available for training. On the other hand, there were instances where
the relationship to the target event was uncertain. They formulated the learning problem as a soft-
label optimization problem and demonstrated that exploiting related examples improved performance.
Their work formed a base for our work on handling the label uncertainty issue in health examination
data presented in Chapter 4.
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2.2.3 Classification with Unlabeled Healthcare Data
In this section, we review key approaches that consider unlabeled healthcare data, namely the Positive
and Unlabeled Learning approach, the Semi-Supervised Learning approach, and the Active Learning
approach.
Positive and Unlabeled Learning Approaches
Methods proposed for handling and utilizing large unlabeled healthcare data are mostly found in a
closely related field of disease gene classification. One common approach is Positive and Unlabeled
(PU) learning [83] that learns from positive and unlabeled data alone. It is used when only the labels
for disease genes are available [130, 131]. For example, Yang et al. introduced an ensemble-based
PU learning approach for robust disease gene prediction.
Recently, Nguyen et al. proposed mPUL [95], a multi-class PU learning model for activity recog-
nition. The method trains m 1-vs-others binary probabilistic base classifiers, each trained with a
positive set and a merged set of negative and unlabeled instances. The class decision was based on
the maximum class probability greater than 0.5; otherwise the unknown class would be predicted.
However, the method did not consider the heterogeneous nature of the examination records. In addi-
tion, their method used a combined set of negative and unlabeled example, while in our case negative
examples are not available, because there is no ground truth for “healthy” participants.
Semi-Supervised Learning Approaches
Semi-Supervised Learning [144] (SSL) that learns from both labeled and unlabeled data has attracted
increasing attention in healthcare applications based on EHRs [73, 60, 97, 46, 124, 61, 84, 138]. PU
learning can be seen as a special case of SSL.
At the molecular level, Huang et al. proposed iSELF [60], a SSL method based on improved local
Fisher discrimination analysis for disease gene classification. Their method was parameter free and
was claimed to be statistically uncorrelated by imposing an uncorrelated constraint on the objective
function. Nguyen et al. [97] constructed a protein-protein interaction network, which defines inter-
acted genes as candidate genes and the rest as negative genes for SSL based on Gaussian fields and
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harmonic functions [144]. In this work, they defined eight scores functions to extract topological and
genomic/proteomic features from six biological databases. The experimental results showed that the
proposed SSL-based method outperforms SVM and KNN classifiers.
At the disease level, many graph-based SSL methods were proposed. Garla et al. [46] applied
Laplacian SVM as a SSL approach for cancer case management based on clinical text data. They
extracted named entities from clinical text and represented each document using a bag-of-word rep-
resentation, which resulted in feature vectors with more than 15,000 dimensions. Their experiments
showed that the Laplacian SVM classifier outperformed the traditional SVM classifier.
Wang et al. [124] proposed a graph-based SSL method that was able to learn patient risk groups
for patient risk stratification. Based on the observation that risk factors and their importance may
vary across different patient groups, they added in their objective function a grouping term that as-
signed patients into risk groups and a matching term that indicated the group assignment and label
prediction. Their proposed method outperformed classical SSL method such as GGSSL [99] on UCI
datasets. They also demonstrated six risk groups identified by their method from a dataset with 1,296
Congestive Heart Failure (CHF) patients.
Kim et al. [73] proposed a co-training graph-based SSL method for breast cancer survivability
prediction that utilized the so-called pseudo-labels. The algorithm iteratively assigns pseudo-labels to
unlabeled data when there was a consensus amongst the learners. In the next iteration, it includes the
pseudo-labeled instances in the labeled set for training. The iteration terminates when the unlabeled
set stops decreasing. Their method has better classification accuracy than ANN, SVM, and standard
SSL classifiers on most of the datasets. Zhang et al. [138] proposed a ranking-based approach for
lung nodule image classification. Their algorithm first constructed a bipartite graph that captures the
relationship between the labeled and unlabeled instances. Based on the constructed bipartite graph,
the similarity scores were computed for the purpose of classification.
To capture the time aspect of the data, Liu et al. [84] constructed a temporal graph based on
medical event sequences of potential patients for temporal phenotyping. They formulated the learning
problem as a matrix reconstruction problem with a goal to minimize the reconstruction error. The
algorithm learned graph bases as phenotypes and their weights. Their proposed temporal phenotyping
approach has been shown to outperform aggregated vector representation and other bag-of-pattern
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representation for classification.
However, different from our case, none of these methods considered an “unknown” class and they
all have predefined instances for all classes, either by experts [60, 46, 124, 73, 138, 84] or via other
mechanisms [97]. In addition, unlike our approach, all the mentioned graph-based SSL methods used
homogeneous graphs. Moreover, each patient was represented by a set of International Classification
of Diseases (ICD) codes in [124], which is very different from a sequence of health examination
records in our problem setting.
Active Learning
Another field of study that addresses the unlabeled data issue is Active Learning [29], where the
concern is how to design a learner that is able to actively acquire data instances from the training set.
Generally speaking, a learning algorithm iteratively selects currently unlabeled instances and queries
an oracle to obtain their labels [16]. It is especially useful in application domains where the amount
of unlabeled data is huge and the availability of oracle, particularly a human expert, is limited.
Active learning has been applied to EHR data predictions [106, 24]. Chen et al. [24] integrated
an uncertainty sampling active learning approach with SVM-based phenotyping algorithms for three
types of diseases, namely rheumatoid arthritis (RA), colorectal cancer (CRC), and venous throm-
boembolism (VTE). The algorithm starts with training an initial SVM classifier with two samples and
the trained model predicts the labels for the rest of the training samples. Then an uncertain sampling
method is used to query a sample closest to the decision hyperplane. The sample is annotated and
included to retrain the SVM learner. This process is repeated until the unlabeled pool is empty.
Qian et al. [106] proposed a query selection strategy that, instead of asking absolute questions
such as labels, the algorithm asked the human experts to answer the relative similarity of the neigh-
boring points to the queried point by placing ordering on them. They formulated the problem as a
quadratic optimization problem that minimizes the reconstruction error of a patient similarity matrix.
The ordering provided by the expert was encoded as the constraints in the optimization problem.
Although active learning is effective with unlabeled data, it is not applicable to our current prob-
lem for the following reasons: First, if a human expert was used as the oracle, it was not available in
our current setting. The label used in this study is Cause of Death (COD) of the health examination
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participants, which would not be obtainable by querying an oracle, but only available when a person
has passed away. Second, if the ground truth labels were to be used as an oracle, we would have
needed a large amount of labels so that some could be hidden in the training phase for the purpose
of evaluation in the testing phase, as most studies on active learning did [16]. But this would require
larger amounts of labeled data. However, this is an unpractical requirement for healthcare data be-
cause our dataset only had 7.4% cases labeled. In addition, using only the available labeled cases
(with some labels hidden) in the experiments would mean limiting the search space of a learner and
the real unlabeled data would be left unexplored.
2.3 Text Mining on Medical Literature
The past decade has witnessed dramatic growth in electronic biomedical literature, which is generated
and stored digitally and is often regarded as a reliable information source [11].
On the one hand, researches have been developing methods to improve document retrieval from
biomedical literature databases [78, 136, 54, 13], such as MEDLINE [3], a bibliographic database
of life science literature, maintained by the U.S. National Library of Medicine. Leonard et al. [78]
proposed a Bayesian approach to mine gene and protein references from MEDLINE abstract and
title. Yoo et al. [136] conducted a comprehensive comparison study to verify if MeSH ontology
would help document clustering for the purpose of improving document retrieval. Haynes et al. [54]
compared search strategies for retrieving scientifically strong studies of treatment from MEDLINE.
Recently, Avillach et al. [13] designed a method to automatically detect known adverse drug reactions
in MEDLINE, based on Medical Subject Headings (MeSH) including “descriptors”, “supplementary
concepts” with subheadings such as “chemically induced”, “adverse effects” and “pharmacological
action”.
On the other hand, more and more studies based on text mining techniques have been developed
for extracting useful knowledge from MEDLINE. De Bruijn et al. [32] proposed a semi-Markov
modeling approach to extract medical concepts such as problem, test, treatment from medical texts.
Padmini et al. [114] used text mining to discover novel uses for Curcuma longa in 2004. They found
that curcumin played a beneficial role in retinal disease, Crohn’s disease, and spinal cord disorders by
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analyzing the influence of curcumin on related genes.
For a network-based approach, Kilicoglu et al. developed SemMedDB [72], a semantic network
for literature-based discovery. The network was composed of entities extracted from MEDLINE,
each represented as a (subject,predicate,object) triple. Kastrin et al. [70] proposed a link prediction
method based on SemMedDB for literature-based discovery. A comprehensive review on literature-
based discovery for novel therapeutic approaches can be found in [59].
In our previous work [20], we proposed MedRank, a ranking-based algorithm for treatment rec-
ommendation on a heterogeneous graph extracted from MEDLINE using MeSH ontology. Ji et al.
[67] proposed a graph-based framework to infer strong relevance heterogeneous entities from unstruc-
tured text. They constructed a heterogeneous graph of five types of entities, namely Drug, Disease,
Compounds, Target and MeSH terms, extracted from MEDLINE literature, with additional domain
specific knowledge from external data sources, such as U.S. Food and Drug Administration (FDA)
approved drugs, human disease ontology, chemical compounds with drug indicator, a dictionary of
targets, as well as the MeSH tree.
Chapter 3
Classification-based Personal Health Index
Prediction Framework
3.1 Problems and Challenges
Health status, being an abstract concept, is often understood through indices or scores that quantize
aspects of well-being into numerical values. Although proven to be very useful, these indices rely
on manual selection of factors based on expert knowledge and validated by epidemiological studies
[69]. Less rigorous indices are also available for personal health management. For example, Nuffield
Health Score [5] computes a user’s health score online based on a set of predefined measurements
uploaded from mobile sensor devices. However, neither of them are adaptive to rapid growth of
information such as the health examination records, as the number of factors to be considered also
growing rapidly.
In this study, we define a new health index called Personal Health Index (PHI) focusing on pro-
viding feedback to individuals based on the evaluation of risks revealed in their health examination
records. PHI provides an overall health score that quantifies a person’s health status against the whole
population, based on data mining technologies.
Perceiving that health is a concept relative to illness, we adopt an approach of “definition by
negation” and assume that a person is healthy if he or she is unlikely to have high health risks.
Further, we view the PHI prediction as a classification problem and define the score based on a class
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membership probability.
Definition 3.1 (PHI). The PHI of a person pi is the complement of the probability that pi is at high
health risk.
The highest health risk is death. We use the main cause of death information as label. The Cause
of Death (COD) dataset stores the cases of people who have been taking General Health Examinations
(GHE) for some years and then have passed away.
For the detailed description of our GHE and COD datasets, readers are directed to Chapter 1.2.1,
where Section 1.1 gives an example of the record sequence of a participant. The key characteristics
of both the GHE and COD datasets are also given in that section. The common attribute in both GHE
and COD datasets is the de-identified Person ID pi. Thus the records in COD dataset can be linked
with that of the GHE dataset. Excluding the deaths that were caused by unexpected situations such
as traffic accidents or crime-related deaths, the health-related death of a person is the highest risk
associated with the GHE records.
In this classification task, we only use the COD information as binary labels, where a positive
label value (+1) indicates that a person has passed away, while a negative label value (-1) is assigned
to a person who is alive, that is, the corresponding record does not have a linked COD label. Note
that in this work we regard the alive cases as the negative cases in our binary classification problem.
However, in our later work on handling unlabeled data in Chapter 5, those alive cases are treated as
unlabeled cases.
Our research problem for mining personal health index is formulated as follows.
Problem 3.1. Given a set of GHE records of M participants, which are linked to COD dataset with
mortality labels yi ∈ {−1,+1}, i ∈ {1, ...,M}, predict PHI for each participant.
3.2 Personal Health Index Prediction Framework
This section describes the proposed PHI prediction framework. As shown in Figure 3.1, the frame-
work contains five main components, namely, data pre-processing, representation extraction, feature
selection, classification, and PHI calibration. The inputs are a population’s archive GHE records
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FIGURE 3.1: An overview of the proposed PHI prediction framework.
linked to a COD database, and the records of a given participant pi. The output is the predicted PHI
score for the person.
3.2.1 Data Pre-processing
As a real-world dataset, GHE data (Section 1.2.1) contains observations collected from a range of
different measurements for the assessments of different parts of the body. This kind of input variety
renders GHE data a mixture of value formats, including numerical, ordinal and categorical values,
as well as free text entries in Mandarin Chinese. Here we describe how issues were handled in the
data-preprocessing stage.
Data Cleaning
As described in Section 1.2.1, there were three fields for recording lab test observations, namely
numerical value, status, and descriptions. Although there were fixed ranges of values for numerical
results and status fields, GHE management system does not have strict constraints on data entry at
the time of data collection. Because of this, we conducted extensive data cleaning to remove extra or
unrecognisable symbols, converted wide characteristics from Asian-based key-in systems into narrow
characteristics, and corrected obvious misspellings.
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Free Text Entries
Most free-text entry fields, such as description for lab test results, doctor suggestions, and patient-
reported disease history, were recorded in plain Chinese text. These fields contained rich information
yet numerous misspellings and synonyms.
Processing this text would require separate research for natural language processing in Chinese
and a comprehensive Chinese medical ontology. We selected fields with less noise, namely, the
“reasons for taking medicine” field. The top seven most frequently reported reasons were extracted.
They were recorded as seven binary attributes, where a value “1” indicates the occurrence of a reason
while a value “0” indicates the absence of that reason.
Missing Values
Missing value is a common issue in medical data. “Missing-ness” observed in our dataset presents
mainly in the following three ways:
• Firstly, a small portion of individual nulls is randomly scattered in the records.
• Secondly, certain test items only appear in the GHE program for some years. So their values
are missing in the records of other years.
• Thirdly, a person may not participate every year, due to the voluntary nature of the program, so
a whole year’s records may be missing.
The average number of check-ups per person in our data was 2.56, which indicates that this type
of “missing-ness” has an impact on the shape of the data. More precisely, if we view a participant’s
records as a high-dimensional longitudinal series, it is likely to be rather short and incomplete. For
this reason, missing value handling is considered together with representation extraction described in
Section 3.2.2.
Binarization
The details of GHE attributes and value handling are discussed in this subsection. Any discrete
attribute obtained according to the process discussed here is then further binarized if they were not
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already in the binary form.
For patient demographics, age was firstly discretized into five-year bins, i.e., [65, 70), [70, 75),
[75, 80), [80, 85), and [85+, where the rounded brackets indicate exclusive interval and the square
brackets indicate inclusive interval.
For patient habits, most attributes are binary except reason-for-taking-medicine which is a patient
reported field. The reasons with top frequency count were extracted and represented as seven binary
attributes as described previously in this section.
For lab tests and physical examinations, there are three fields to record the results, namely ob-
served value, status, and description. The observed values are generally numeric. The status fields
indicate whether or not the result of a test is normal. Their values can be either binary or ordinal,
depending on the type of tests. The descriptions are in free text format. We only used the information
from the status fields for the following reasons.
• Firstly, the reference ranges of these items may differ among hospitals and the information
regarding where an examination was taken is not available in the dataset for privacy reasons.
• Secondly, the values for the description fields are mostly missing.
The results of five Brief Symptom Rating Scale (BSRS) questions for mental health assessments
were encoded as ordinal values, in terms of degree of severity, i.e., normal, mild, medium, and severe.
For the Short Portable Mental Status Questionnaire (SPMSQ) cognitive function assessment, the
overall result was scored in terms of the number of questions that were incorrectly answered. It is an
ordinal attribute with values “sound” (0-5 scores), “mild” (6-9 scores), “medium” (10-14 scores), and
“severe” (above 15 scores) according to the standard categorization.
3.2.2 Representation Extraction
Feature extraction is a critical step in our framework, because the performance of a classifier is ul-
timately determined by the amount of information conveyed in input data. In the literature many
transformation algorithms for time-series data were proposed, such as wavelet-based transformation
and the Symbolic Aggregate approXimation (SAX) transformation [123]. These methods were usu-
ally applied to high-frequency time-series, such as ECG signals recorded in the scale of Hz [109].
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Instead of classifying directly on the longitudinal data, we took a feature-based approach [129]
that reduces sequence classification into a point-based classification due to the facts.
• Firstly, classical point-based classifiers can be applied.
• Secondly, the missing value issue can be implicitly handled in such reduction.
Four representation strategies are defined to extract patient feature vectors from the GHE record
sequences. The first two are baseline methods and last two are our proposed methods, as discussed
below in order:
• Avg is our first baseline method that averages over a participant pi’s ni records ri across time
on every dimension separately:
Avg(ri) = 1/ni ·
ni∑
j=1
vij. (3.1)
where ri = ((tij, vij))j∈{1,...,ni}.
Although this approach considers all the records of pi, it does not capture the longitudinal aspect
of a participant’s records, because it treats every year equally.
• Last is our second baseline method. It uses the last GHE record of the record sequence, i.e.,
vini , to represent a participant pi’s records throughout years:
Last(ri) = vini (3.2)
The intuition behind this method is that the latest record best reflects the current status of a
person’s health.
• Stacked is our first proposed method. It was designed as a combination of the baselines, in order
to capture their advantages. This approach stacks the Avg representation of pi’s all previous
records except the last one and the Last representation to form a new feature vector:
Stacked(ri) = [Avg(ri(m)), Last(ri)] (3.3)
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This design emphasizes the importance of the latest record, while it still takes the previous
records into account. Note that previous records are weighted equally in this approach.
• Decay is our second proposed method. It assigns weights to the records in a sequence according
to their recency.
A normalized exponential decay function Kα(·) with a decay scale α is defined as follows:
Kα(x) =

e−αx∑H−1
t=0 e
−αx t ∈ [0, H − 1]
0 otherwise
(3.4)
where H is the window of the years under consideration.
Given a participant pi’s jth record (tij, vij) of his record sequence ((ti1, vi1), ..., (tini , vini)), the
weight of (tij, vij) is computed by Kα(tini − tij), because the direction of decay is from the
latest time backwards to capture the recency.
So, the Decay representation is computed by the following function:
Decay(ri) =
ni∑
j=1
Kα(tini − tij) · vij (3.5)
Should any null values exist after the above extraction process, they are imputed with zero.
3.2.3 Feature Selection
In order to avoid noise from irrelevant features and discover key factors, we further included a fea-
ture selection step in the framework. This step was designed especially for non-linear kernels to be
discussed in Section 3.2.4, because they do not compute feature weights in the original feature space.
Two selection approaches are considered, namely univariate feature selection and L1 regularization.
Univariate F-score Feature Selection
This approach computes feature score independently for each feature. The F score of feature j is
computed by Eq. (3.6) as in [25]:
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F (j) =
(xj
(+)−xj)2+(xj(−)−xj)2
1/(n+−1)
∑n+
i=1(x
(+)
i,j −xj(+))2+1/(n−−1)
∑n−
i=1(x
(−)
i,j −xj(−))2
(3.6)
where xj , xj(+) and xj(−) are the average of the jth feature of the whole, positive, and negative
datasets, respectively; x(+)i,j is the jth feature of the ith positive instance and x
(−)
i,j is the jth feature of
the ith negative instance.
All features were ordered according to their F scores computed according to Eq. (3.6). Then a
subset of features was selected based on a user-defined percentile of top-scored features.
L1 Regularization
L1 regularization uses a penalty term that encourages the sum of the absolute values of parameters to
be small, which frequently leads to a sparse parameter vector. This mechanism has been commonly
used for feature selection.
For linear classifiers, L1 regularization can be embedded as an extra term in an objective function;
however for non-linear models an extra step is needed. Here we use Logistic Regression with L1
regularization [94] as a method for feature selection. Logistic Regression models the conditional
probability Pw(y = ±1|x). The prime problem with the L1-norm regularization is defined:
min
w
||w||1 + C
l∑
i=1
log(1 + e−yiw
Txi) (3.7)
wherew is a weight vector and the meta-parameter C controls the sparsity ofw. Features are selected
by w.
3.2.4 Classification Models
Recall that the proposed PHI defined earlier in Definition 3.1 was computed based on the class mem-
bership of the high risk class. For this classification task, we applied the popular Support Vector
Machines (SVM) algorithm [112] with various kernels. SVM finds the decision boundary that maxi-
mizes the margin, i.e., the distance between the boundary hyperplane. The nearest class instances that
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define the margin are called the support vectors.
To allow possible overlapping class distributions, we adopted a soft-margin SVM with slack vari-
ables ξi ≥ 0. Given a training set (xi, yi), i = 1, ..., l where xi ∈ <D and y ∈ {1,−1}, the lost
function is defined as:
min
w,b,ξ
wTw + C
m∑
i=1
ξi
subject to yi(wTφ(xi) + b) ≥ 1− ξi, ξi ≥ 0
where C > 0 is the penalty of the error term, and K(xi,xj) = φ(xi)Tφ(xj) is the kernel function.
Three commonly used kernels, namely the linear (LinSVM), radial basis function (SVM-RBF),
and sigmoid kernels (SVM-Sigmoid), are considered in our framework. They are listed below, with
kernel parameters γ and r.
• Linear kernel:
K(xi,xj) = xi
Txj
• RBF kernel:
K(xi,xj) = exp(−γ‖xi − xj‖2), γ > 0
• Sigmoid kernel:
K(xi,xj) = tanh(γxi
Txj + r)
3.2.5 Personal Health Index Calibration
To further compute PHI based on classification results, we use Platt’s scaling [81] to transform the out-
puts of a classification model into a probability distribution over classes. The Platt’s scaling method
is defined as follows:
Pr(y = 1|x) ≈ PA,B(f) = 1
1 + eAf+B
(3.8)
where f is the decision function of SVM classifier, and A,B are the parameters to be learned.
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With this probability of the high mortality risk class (y = 1), PHI is computed as:
PHI(x) = 1− Pr(y = 1|x) (3.9)
By definition, PHI is a value within the range of [0,1].
3.3 Experiments and Results
In this section, we report and analyze our experiment results. Since we are handling record sequences,
how these sequences are aligned will be explained first. Then the experiment setup and evaluation
measures will be defined. Finally, the analysis of the experimental results and discussion will be
given.
3.3.1 Data Alignment
It has been observed in the deceased cases that time gap between a participant’s last record and death
varies, which implies that the predictability of participants’ record sequences also varies. In order to
align participant sequences, we selected data subsets by defining the upper bound on the time gap k.
Three data subsets, S1, S2, and S3 were generated by selecting from the original dataset which we
refer to as S0. S1, S2, and S3 contain participants who are deceased/alive within k years (k = 1, 2, 3)
of their last check-up.
For example, S1 data subset contains all records of participants who passed away within the first
year of their last check-up (positive cases) or those who were alive within the time frame (negative
cases). The sizes of the subsets are listed in Table 3.1. If we denote Sk(d) and Sk(a) as the deceased
and alive cases of the within-k-year subset, the relationships between these subsets are as follows:
S1(d) ⊂ S2(d) ⊂ S3(d)
and
S3(a) ⊂ S2(a) ⊂ S1(a)
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TABLE 3.1: Within k year subset statistics (before resampling)
Within k Number of participants Number of records
year subset deceased % alive deceased % alive
S1(k = 1) 1,469 2.4 59,021 4,415 2.0 215,462
S2(k = 2) 2,433 4.0 58,057 7,100 3.2 212,777
S3(k = 3) 2,920 4.8 57,570 8,309 3.7 211,568
where A ⊂ B means set A is a strict subset of set B.
Note that the percentages of positive cases (deceased) for S1, S2, S3 are 2.4%, 4.0% and 4.8%
respectively and 7.4% for the whole dataset S0. These figures indicate that class distributions of
the subsets and the whole dataset are heavily imbalanced. To handle this class imbalance issue, we
performed an adaptive re-sampling method called one side selection [12] on each subset. In a binary
classification scenario, the method randomly sampled from the majority class the same number of
participants as the minority class. For the rest of the chapter, we use S1, S2, S3 to denote the re-
sampled within 1, 2, 3 year subsets respectively. Their sizes have |S1| < |S2| < |S3| relationships,
where | · | denotes the size.
3.3.2 Experiment Setup
We used a Dell workstation with common specification (CPU i7 and 16GB RAM) for the experiments.
The experiments were conducted on subsets S1, S2, S3 separately on four representations defined in
Section 3.2.2. In addition to SVM classifiers, we included the other two popular classifiers in medical
applications, namely K-Nearest Neighbour (KNN) and the CART decision tree model as baselines
[7].
In order to fully utilize the data, we conducted 10-fold cross-validation in all experiments. In each
fold, three steps are performed as follows.
• Step 1: feature selection models were trained and applied to transform training and testing sets.
• Step 2: classifiers were trained with the transformed training set using 5-fold cross-validation
grid search for the optimal meta-parameter C for all SVM classifiers and γ for SVMs with RBF
and Sigmoid kernel. All parameters were tuned in the range of {10−4, 10−2, 100, 102, 104}.
• Step 3: the learned classifiers were tested with the transformed testing set.
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The algorithms were implemented in Python using LibSVM [18] and scikit-learn [7] packages.
3.3.3 Evaluation Measures
For the purpose of evaluating the binary classification results, we adopted five commonly used mea-
sures. In order to define these measures, we first define the following notations known as the confusion
matrix.
• True Positive (TP ): the number of correctly predicted positive cases.
• True Negative (TN ): the number of correctly predicted negative cases.
• False Positive (FP ): the number of negative cases that was incorrectly predicted as positive
cases.
• False Negative (FN ): the number of positive cases that was incorrectly predicted as negative
cases.
The five measures used for our evaluation are Accuracy, Precision, Recall, F1-score, and Area
Under the receiver operator characteristic Curve (AUC), which are defined as follows.
• Accuracy computes the portion of correct predicted cases amongst all cases.
Accuracy =
TP + TN
TP + TN + FP + FN
• Precision calculates the portion of predicated positive class that is actually correct.
Precision =
TP
TP + FP
• Recall computes the portion of ground truth class that is correctly predicted.
Recall =
TP
TP + FN
Recall is also known in the medical domain as the sensitivity.
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FIGURE 3.2: Comparing representation extraction methods by classifiers in AUC (LinSVM).
• F1-score is a harmonic mean of precision and recall, defined as:
F1Score =
2 · precision · recall
precision+ recall
• AUC measures the area under the Receiver Operator Characteristic (ROC) curve. Each point
on the ROC curve is plotted with the true positive rates or sensitivity and false negative rates or
1-specificity of a given prediction threshold.
3.3.4 Results
In this subsection we analyse the experiment results. The averaged training and testing time with
non-linear kernel SVM plus feature selection were 35.21 seconds and 0.07 seconds respectively. The
effectiveness of the proposed framework was demonstrated via experimental studies discussed below.
As will be shown, the best performance was seen at 77.98% AUC with F-score feature selection.
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FIGURE 3.3: Comparing representation extraction methods by classifiers in AUC (SVM-RBF).
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FIGURE 3.4: Comparing representation extraction methods by classifiers in AUC (SVM-sigmoid).
Representation Extraction Comparison
First, we compared four representation extraction strategies. The figures from Figure 3.2 to 3.4 show
the results of SVM classifiers (with linear, RBF, and sigmoid kernels respectively) in AUC scores and
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FIGURE 3.5: Comparing representation extraction methods by classifiers in AUC (KNN).
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FIGURE 3.6: Comparing representation extraction methods by classifiers in AUC (CART).
the subsets are listed in a size-increasing order. Figure 3.5 and Figure 3.6 show the results for KNN
and CART classifiers in AUC scores. The parameter α for Decay representation was set to 1. As a
general trend, the performance of different methods increase with the increase of the subset size.
46 CLASSIFICATION-BASED PERSONAL HEALTH INDEX PREDICTION FRAMEWORK
	

  


















	
	
FIGURE 3.7: Comparing representation extraction methods with SVM-RBF (Accuracy).
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FIGURE 3.8: Comparing representation extraction methods with SVM-RBF (Precision).
The best performance was seen with Stacked representation at 77.46% AUC in Figure 3.3, achieved
by SVM with RBF kernel on subset S3. In general, the proposed Stacked and Decay representations
constantly outperform the baseline Avg and Last representations on all subsets with SVM classifiers,
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FIGURE 3.9: Comparing representation extraction methods with SVM-RBF (Recall).
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FIGURE 3.10: Comparing representation extraction methods with SVM-RBF (AUC).
although it was less obvious in the case of KNN and CART. Since SVM-RBF constantly gave the best
performance, we will focus on its results in the following discussion.
The stability of the proposed representations can be further observed in Figure 3.7 to Figure 3.11,
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FIGURE 3.11: Comparing representation extraction methods with SVM-RBF (F score).
which show the performance in all evaluation measures. It is clear that the proposed Stacked and
Decay consistently outperform baseline methods in all five measures and on all subsets. However,
there is no clear winner between the Stacked and Decay methods.
The effect of setting parameter α for Eq. (3.4) are displayed in Figure 3.12 and Figure 3.13 in
AUC scores. The range of values experimented were {1/25, 1/5, 1, 5, 25}. It can be observed that
α = 1 consistently delivers the best performance.
Feature Selection and Factor Analysis
To investigate the effects of feature selection and the selected subsets, we further conducted experi-
ments with the Univariate F-score method (F-univariate) and the Logistic Regression model with L1
regularization (LR-L1) for feature selection. Table 3.2 to Table 3.4 show the selected feature sizes
of LR-L1 over C in the range {0.005, 0.01, 0.05, 0.1, 1}. The corresponding percentile (%) for fea-
ture selection is also given and NoFS denotes the base case without selection. Note that Stacked
representation has twice as many features than Decay.
The figures from Figure 3.15 to Figure 3.17 show the results of feature selection on the proposed
representations in AUC scores. The range of selection percentile for F-univariate is {5%, 10%, ..., 60%}
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FIGURE 3.12: Parameter α tuning for Decay feature representation in AUC, within the value range
{1/25, 1/5, 1, 5, 25} (LinSVM).
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FIGURE 3.13: Parameter α tuning for Decay feature representation in AUC, within the value range
{1/25, 1/5, 1, 5, 25} (SVM-RBF).
and 100 percentile also refers to the base case without selection. It can be seen that F-univariate
constantly improves the performance. The best performance was achieved at 77.98% on subset S3,
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FIGURE 3.14: Parameter α tuning for Decay feature representation in AUC, within the value range
{1/25, 1/5, 1, 5, 25} (SVM-sigmoid).
TABLE 3.2: Average number of selected features by LR-L1 with a range of C values on Dataset S1
S1
C Stacked % Decay %
NoFS 178.0 100.0 89 100.0
1 106.9 ± 1.03 60.1 57 ± 2.06 64.1
0.1 30.5 ± 0.92 17.1 19.6 ± 0.85 22.1
0.05 18.7 ± 0.26 10.5 11.9 ± 0.57 13.4
0.01 3.7 ± 0.26 2.1 2.9 ± 0.32 3.3
0.005 2.6 ± 0.43 1.5 1.6 ± 0.53 1.7
TABLE 3.3: Average number of selected features by LR-L1 with a range of C values on Dataset S2
S2
C Stacked % Decay %
NoFS 178 100.0 89 100.0
1 125.3 ± 1.72 70.4 66.7 ± 2.28 37.5
0.1 45.8 ± 0.97 25.8 27.8 ± 1.32 15.7
0.05 22.1 ± 0.58 12.4 15.5 ± 0.52 8.7
0.01 7.0 ± 0.41 4.0 5.7 ± 0.52 3.2
0.005 3.0 ± 0.16 1.7 2.1 ± 0.01 1.2
0.51% higher than the base case, based on 50 percentile selection on the Stacked representation (Fig-
ure 3.17). Similarly, Decay obtains 77.87% on the same subset, and 0.75% improvement on the base
case, based on only 20% of the features.
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TABLE 3.4: Average number of selected features by LR-L1 with a range of C values on Dataset S3.
S3
C Stacked % Decay %
NoFS 178 100.0 89 100.0
1 127.4 ± 1.09 71.6 68.7 ± 2.01 77.2
0.1 46 ± 0.82 25.9 27.3 ± 1.16 30.7
0.05 28.4 ± 0.42 15.9 16.5 ± 0.97 18.5
0.01 9.2 ± 0.32 5.2 7.3 ± 0.43 8.1
0.005 3.1 ± 0.01 1.7 2.1 ± 0.01 2.3
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FIGURE 3.15: Effects of F-univariate feature selection methods on subsets S1 in AUC. The per-
centile of F-univariate is in the range of {5%, 10%, ..., 60%, 100%}, where 100 refers to no selection
On the other hand, Figure 3.18 to Figure 3.20 show the results of feature selection with LR-L1
on subsets S1 − S3 in AUC. The parameter C for LR-L1 is in the range of {0.005, 0.01, 0.05, 0.1, 1}
and “NoFS” denotes no selection. It can be seen the LR-L1 had no improvement on the performance;
rather the performance drops with the decrease of the value of C.
We further investigated risk factors that played key roles in the classification. This information
could provide explanations especially to those who were predicted with a low PHI. For the purpose
of reporting selected features with a displayable size, we show the results of two selection methods
with the selected size as close as possible in Table 3.5 and Table 3.6. Table 3.5 lists the nine features
selected by LR-L1 on the Decay representation with C = 0.01 and AUC 73.64%. Since the last
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FIGURE 3.16: Effects of F-univariate feature selection methods on subsets S2 in AUC. The per-
centile of F-univariate is in the range of {5%, 10%, ..., 60%, 100%}, where 100 refers to no selection
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FIGURE 3.17: Effects of F-univariate feature selection methods on subsets S3 in AUC. The per-
centile of F-univariate is in the range of {5%, 10%, ..., 60%, 100%}, where 100 refers to no selection
two features were only selected once out of ten in 10-fold cross validation, the averaged number of
selected features is 8.1%. Table 3.6 shows the features selected by F-univariate at a slightly larger
3.3 EXPERIMENTS AND RESULTS 53
	

	 	














FIGURE 3.18: Effects of LR-L1 feature selection methods on subsets S1 in AUC. The parameter C
for LR-L1 is in the range of {0.005, 0.01, 0.05, 0.1, 1} and “NoFS” denotes no selection.
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FIGURE 3.19: Effects of LR-L1 feature selection methods on subsets S2 in AUC. The parameter C
for LR-L1 is in the range of {0.005, 0.01, 0.05, 0.1, 1} and “NoFS” denotes no selection.
percentile, i.e., 10%, with an AUC score of 75.34%. The lists are ordered by feature scores output by
selection methods.
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FIGURE 3.20: Effects of LR-L1 feature selection methods on subsets S3 in AUC. The parameter C
for LR-L1 is in the range of {0.005, 0.01, 0.05, 0.1, 1} and “NoFS” denotes no selection.
TABLE 3.5: Selected risk factors by LR− L1 feature selection method.
LR-L1
Factor score (AbsAvg ± std)
1 hemoglobin (hb) 0.73 ± 0.0651
2 age 0.38 ± 0.0061
3 SPMSQ 0.37 ± 0.0234
4 tsh 0.16 ± 0.0906
5 exercise 0.09 ± 0.0157
6 BMI 0.07 ± 0.0185
7 education level 0.02 ± 0.0043
8 hematocrit (hct) < 0.001 ± 0.0013
9 mch < 0.001 ± 0.0005
Out of the nine features selected by these two methods, six of them overlapped, i.e., hemoglobin
(hb), age, SPMSQ cognitive function assessment, thyroid stimulating hormone (tsh), hematocrit (hct),
and mean corpuscular hemoglobin (mch). Amongst them, three were ranked top four by both meth-
ods. Hb test, for example, reveals the blood glucose levels, which is an important indicator for dia-
betes. Although age is a known factor for mortality, Table 3.5 and Table 3.6 show that its combination
with other factors, say poor cognitive functions (i.e., SPMSQ), led to high mortality risks.
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TABLE 3.6: Selected risk factors by F-univariate feature selection method.
F-univariate
Factor score (AbsAvg ± std)
1 age 781 ± 17.18
2 hemoglobin (hb) 769 ± 24.39
3 hematocrit (hct) 669 ± 21.21
4 tsh 574 ± 23.57
5 SPMSQ 351 ± 6.95
6 mch 342 ± 11.20
7 albumin (alb) 307 ± 7.12
8 waist 260 ± 9.87
9 red blood cell 239 ± 18.89
Personal Health Index Applications
To illustrate the usefulness of PHI, we first include a dashboard of regional health in Figure 3.21. It
shows the averaged PHIs of the 12 districts of Taipei City computed based on the full GHE dataset.
On the right-hand map, the corresponding regions are colored based on a color spectrum from red to
green denoting PHI in the [0.5,1.0] range. The districts are indexed by their zip codes. The average
PHI is 0.8852±0.008 with standard deviation. Such information can reveal regional health conditions
and assist local government’s fine-tuning health policies.
In addition, Figure 3.22 presents a dashboard of a person’s health status summary, where yearly
PHI scores are displayed on the top right chart. Detailed examination results can be compared across
years via the PHI fingerprint on the left as a concentric circle. It shows the severity of individual test
results, where an annulus represents the results of a year.
3.3.5 Discussion
From the results demonstrated in Section 3.3.4, we have demonstrated the effectiveness of our pro-
posed classification-based PHI prediction framework. We compared the performance of SVM classi-
fiers with linear, RBF, and sigmoid kernels, as well as KNN and CART classifiers. The best prediction
was achieved at 77.98% AUC on the proposed Stacked representation plus F-univariate (Figure 3.15
to Figure 3.17). Although our experiments were based on one dataset, it is a large and comprehensive
GHE dataset with 102,258 participants.
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FIGURE 3.21: A dashboard of Taipei City’s regional health based on PHI. The left-hand chart
displays the regional PHI of twelve districts of Taipei City. The map on the right has the corresponding
districts coloured based on a colour spectrum from red to green denoting PHI in the [0.5,1.0] range.
The districts are indexed by their zip codes.
The proposed Stacked and Decay representation extraction strategies were also shown to consis-
tently outperform the baseline Avg and Last methods in all five measures (Figure 3.2 to Figure 3.11).
This verifies the intuition that the latest GHE record is most indicative while historical records are
still accountable for health status prediction.
The similar performances of Stacked and Decay suggest that weighting historical records equally
or as a time-decay function has little effect on the performance. Also from the fact that Stacked has
twice as many dimensions than Decay, we conclude that Decay is preferred when dimensionality of
given data is high.
F-univariate feature selection was shown to constantly improve performances (Figure 3.15 to
Figure 3.17), while LR-L1 dragged the performances down (Figure 3.18 to Figure 3.20). We further
showed displayable lists of selected features in Table 3.5 and Table 3.6. This information can be
useful for providing explanations especially to those predicted with low PHI. Finally, two application
examples of PHI were given in Figure 3.21 and Figure 3.22, which show the applicability of PHI at
both population and individual levels.
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FIGURE 3.22: A dashboard of a person’s health status summary. PHI is computed based on GHE
results for each year and summarized in the bar chart on the right. PHI fingerprint on the left is a
breakdown of PHIs into details, where an annulus of the concentric circle represents the results of a
year and a sector in an annulus denotes a test result of the year. Colour indicates severity and the
white annuluses denote no attendance.
3.4 Summary
Computing a comprehensive health score for every citizen was impossible before the big data era.
Because of the wide availability of multiple sources of data collected from all kinds of devices over
many years, effectively evaluating health status of a person from-cradle-to-grave is becoming possi-
ble. One example of such a data source is the annual Geriatric Health Examination (GHE) which is
now an integral part of elderly healthcare for many developed countries.
Predicting personal health status based on health examinations reveals a promising and impor-
tant trend in healthcare research. In this work, we took the first step by making such predictions
from longitudinal GHE records of 102,258 participants. Particularly, we defined the Personal Health
Index (PHI) to quantize health status and developed a classification-based prediction framework to
effectively infer a person’s PHI.
The effectiveness and stability of the proposed framework have been demonstrated via our ex-
tensive experiments. The best prediction was achieved at 77.98% AUC on the proposed Stacked
representation method with feature selection. It has also demonstrated that the proposed methods
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consistently outperform the baselines in all five evaluation measures.
Chapter 4
Disease-level Classification with Label
Uncertainty
4.1 Problems and Challenges
In the last decade, an increasing number of data mining applications have been developed to support
healthcare decision making [37, 134]. Of particular focus in recent years has been studies in the
area of clinical risk classification [122, 121, 127, 88, 92]. These studies generally treat class labels
with 100% certainty. However, label uncertainty is commonly found in clinical judgments due to
subjectivity and inadequate information [104]. Often it has been handled as noise, and the task has
been to detect and correct mislabeling [87, 107, 45]. However, in the case of multiple, non-exclusive
medical conditions [82], such as comorbidity, it makes more sense to treat labels with degrees of
certainty rather than forcing them to belong to one “true” class.
Recently in the field of Computer Vision, Yi et al. introduced a soft-label learning model for
complex event detection on Web videos [133]. For a given small number of target event instances, the
model leverages instances where their relationship to the target event is uncertain and to be learned.
Inspired by this work, we formulated the PHI prediction problem as a soft-label optimization problem.
In the process of soft-label learning, we distinguished the following three types of instances:
• participants with a target COD label,
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• participants with a non-target COD label, and
• participants without a COD label.
Note that in the above list, a “target” COD refers to the COD of interest to be predicted.
Traditionally, in a binary prediction problem on a target event, instances of the first type are
regarded as positive and those of the other two types, namely those with a non-target labels and those
without a label, are treated as negative. However, in our case, participant records with different COD
labels might share similar traits due to comorbidity, so some non-target instances could be “related”
to the target ones. The method we propose is designed to capture the differences amongst these three
types of instances.
This work substantially improved our previous work presented in Chapter 3.
• Firstly, we extended the concept of PHI from a single overall health score based on all-cause
mortality to a vector of scores, each reflecting personal health risk in a disease category; and
• Secondly, rather than treating labels as 100% certain, as in our previous work, we took a soft-
label learning approach to handle label uncertainty.
Experimentally we demonstrated the effectiveness of MyPHI based on a large Geriatric Health
Examination (GHE) data set of 262,424 records from 102,258 participants.
The rest of the chapter is organized as follows. Section 4.2 details our MyPHI method and high-
lights the optimization technique employed to construct the prediction model. In Section 4.3, we
demonstrate the effectiveness of our method through extensive experiments. Section 4.4 is our sum-
mary and findings.
4.2 The Methodology
The proposed MyPHI prediction method that computes Personal Health Index (PHI) for elderly
healthcare contains three key components, namely data pre-processing, feature extraction, and model
learning with uncertainty, as shown in Figure 4.1. The inputs of the method are the Geriatric Health
Examination (GHE) records of a population linked to the main Cause of Death (COD) database. The
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FIGURE 4.1: The process of Personal Health Index (PHI) prediction
output is a vector of k predicted scores in the range of [0, 1] interval, reflecting personal health risks in
k disease categories. Note that the algorithm is designed for medical datasets that share the character-
istics described in Section 1.2.2 of Chapter 1. Although in the following discussions we will use the
GHE dataset as an example, the applicability of our proposed method is not limited to that dataset.
4.2.1 Data Pre-processing
The datasets used in this work include a Geriatric Health Examination (GHE) dataset linked to a
Cause of Death (COD) dataset. For detailed descriptions of these datasets and their characteristics,
please refer to Section 1.2.1.
In this work, we adopted an event-based view that treated an observed abnormal result as an occur-
rence of an abnormal event. This approach was based on the practice of evidence-based medicine that
only took the observed symptoms and signs into account in clinical diagnosis. For binary variable,
abnormality was encoded as 1, and 0 otherwise. Real values were firstly discretized into bins. Ordi-
nal and categorical variables were binarized into a vector of binary variables representing the unique
values of the original variables. A variable took the value 1 if the original variable took the corre-
sponding value; otherwise, it was 0. For the details of data preprocessing, especially about handling
attributes of different data formats, please refer to Section 3.2.1 of Chapter 3. Since GHE records are
essentially longitudinal, participants with only one record are excluded from consideration. This left
us with a subset of 221,074 records from 60,881 participants.
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After the pre-processing stage, participant longitudinal records could be represented as a sequence
of time-stamped records, which then can be formally defined as follows:
Definition 4.1 (Record sequence). A record sequence si of a person pi is an ordered list of m records
〈ri1, ..., rij, ..., rim〉, where record rij is a tuple (tij, vij) of a d dimensional binary vector vij of values
observed at time tij , where tij is the normalized time mapped onto an integer space such that tij ∈ N
and tij < tij+1.
4.2.2 Feature Extraction
One of the key challenges we faced was how to model and represent a participant’s record sequence in
our framework. To begin with, a participant could have multiple records as depicted earlier in Figure
1.1 of Chapter 1, so it is not naturally in the form of a feature vector. However, these records cannot
be simply flattened into a feature vector because record sequences of participants have varied lengths.
On the other hand, these record sequences were not like the traditional time series such as ECG series,
because they were infrequent, as discussed in Section 1.2.2. In fact, the average number of records
per participant was 2.56.
In this work, we took a feature-based approach [129] that converted sequences into a point-based
representation, i.e., by transforming a sequence into a vector of features. So the problem became,
“How do we design a transformation mechanism that has a greater ability to capture different shapes
of curves?”
Our previous work on representation extraction strategies (Chapter 3, [22]) suggested that time
smoothing kernels that assign time weight to values at time t outperformed methods without consid-
ering the longitudinal progression. Based on the previous results, we designed a chi-squared kernel in
our current work to model the changes of importance over time. This was chosen over the commonly
used Gaussian distribution because it had a greater ability in capturing different shapes of curves.
The probability density function of the chi-squared distribution is defined as:
f(t, θ) =

tθ/2−1e−t/2
2θ/2Γ(θ/2)
t ≥ 0
0 otherwise
(4.1)
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Algorithm 1 Feature Extraction
Input: S: a list of record sequences, θ: a scale parameter for the temporal weighting kernel, T : the
time window of interest.
Output: X: extracted feature vector of S.
X := []
while i < size(S) do
((tij, vij))j∈1...ni := S(i)
X(i) :=
∑ni
j=1 Kθ(T − tij + 1) · vij
end while
return X
where θ is the degree of freedom, Γ(·) is the Gamma function, and t in our case is a parameter that
takes integers greater than zero.
The chi-squared kernel is defined as a function of truncated chi-squared distribution:
Kθ(t) =

f(t,θ)
Φ(T )−Φ(1) t ∈ [1, T ]
0 otherwise
(4.2)
where Φ(·) is the cumulative distribution function of f(·) and T the window length.
The record sequence si of a person pi is then transformed into a vector xi using Eq.(4.2):
xi =
m∑
j=1
Kθ(T − tij + 1) · vij (4.3)
where the (T − tij + 1) term reverses the time ordering, resulting in a larger weight to the latest
records; vij is the jth record of si obtained at time tij .
The full procedure of feature extraction is summarized in Algorithm 1. It takes a list of record
sequences S of length n, a scale parameter θ for the temporal weighting kernel, and T as the time
window width of interest as inputs. It iterates through the sequence list and transforms every sequence
into a feature vector using the weighting kernel based on the scale parameter. The output is a n×m
matrix X , where m is the dimension of the feature vector.
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4.2.3 Model Learning with Label Uncertainty
To build an effective PHI prediction model for the elderly, we trained k models, each for a target
disease category. As discussed earlier in Section 4.1, there can be a degree of uncertainty that a COD
label is assigned to a particular person. This uncertainty can be observed in two types of instances,
namely the target disease instances (known as the positive examples), and the non-target disease
instances (usually treated as the negative examples). Intuitively, different people can belong to a
target disease in different degrees. In addition, non-target cases and alive cases, though all considered
negative examples in the traditional sense, are “negative” in different ways: non-target cases may be
closer to the target cases in the feature space than to the alive cases.
Optimization Problem
Due to the uncertainty of labels, we formulated the problem as an optimization problem [133] that
finds a soft label for every instance. More specifically, given training instances X = {x1, ..., xn}
converted from n record sequences using Eq. (4.3), the soft label Yi of xi is 1+Si for target instances,
1− Si for non-target instances, and 0 for alive instances, where Si expresses a degree of certainty to
be learned.
This design can be expressed by defining:
Y = Y a + A S
where A  S is the entrywise product of vectors A ∈ Rn, S ∈ Rn, S ≥ 0, and Y ai is defined as
follows:
Y ai =

1 for the target and non-target instances
0 otherwise
and Ai is defined as follows:
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Ai =

1 for the target instances
−1 for the non-target instances
0 otherwise
So the optimization problem can be defined as a regularized least squared minimization problem
with additional constraints on Y and S:
min
P,S,Y
||XTP − Y ||2F + Ω(P )
s.t. Y = Y a + A S, S ≥ 0
(4.4)
where Ω(·) is a regularization term on P to prevent over-fitting and || · ||F denotes the Frobenius norm
over a m× n matrix B such that:
||B||F = (
m∑
i=1
n∑
j=1
|bij|2)1/2
We further postulate that noises of the labels were mostly from the non-target disease cases, as
these cases could exhibit similar or completely different traits to the target cases. So a weight vector
W was introduced, which is learned only using the target disease instances and alive instances. By
applying trace norm || · ||∗ on E = [W,P ], P can be further constrained by W , as the trace-norm can
uncover the shared knowledge of W and P [132]. The optimization problem is modified as:
min
W,P,S,Y
||X˜TW − Y˜ ||2F + ||XTP − Y ||2F
+α(||W ||2F + ||P ||2F ) + β||E||∗
s.t. Y = Y a + A S, E = [W,P ], S ≥ 0
(4.5)
where X˜ is the input data for the target and alive cases only, W and P are regularized using the
Frobenius norm to prevent over-fitting, and together (i.e., E) they are further regularized using the
trace-norm. α and β are the coefficients for the regularization terms, and Y˜ is the corresponding
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label:
Y˜i =

1 for the target cases
0 for the alive cases
Optimization Procedure
We now describe the procedure of solving the optimization problem formulated in Eq. (4.5). Let
D = 1
2
(EET)−
1
2
Eq. (4.5) can be converted to:
min
W,P,S,Y
||X˜TW − Y˜ ||2F + ||XTP − Y ||2F
+α(||W ||2F + ||P ||2F ) + βTr(ETDE)
s.t. Y = Y a + A S, E = [W,P ], S ≥ 0
(4.6)
Eq. (4.6) can be solved through iteratively updating P , W , and S until convergence, by setting
their partial derivatives to zero, one at a time, and solving it accordingly. The convergence has been
proven in [133]. By setting the derivative of Eq. (4.6) w.r.t. P to 0, we have:
P = (XXT + αI + βD)−1XY (4.7)
Again, by fixing P and setting the derivative of Eq. (4.6) w.r.t. W to 0, we get:
W = (X˜X˜T + αI + βD)−1X˜Y˜ (4.8)
Optimizing S is to solve the following problem:
min
S≥0
||XTP − (Y a + A S)||2F (4.9)
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Algorithm 2 Learning with Uncertain Labels
Input: X ∈ Rd×n: extracted d dimensional feature vectors of n participants, X˜ ⊆ X: a subset of X
of size m, containing only the target and alive cases, Y˜ ∈ Rm×1: the corresponding labels of X˜ ,
Y a ∈ Rn×1 and A ∈ Rn×1: parameters for learning uncertain labels.
Output: Optimized W , P , S.
Set t = 0 and initialize W , P randomly;
repeat
Compute Dt as: Dt = 12(EtE
T
t )
−1
2 ;
Update Pt according to Eq. (4.7);
Update Wt according to Eq. (4.8);
Compute Mt = XTPt − Y a;
Compute St by Stij = max(Mtij/Aij, 0) (Eq. (4.11));
t = t+ 1
until Convergence
Let M = XTP − Y a. The problem then becomes:
min
S≥0
||M − A S)||2F (4.10)
Finally, the optimal solution to Eq. (4.10) is obtained by:
Sij = max(Mij/Aij, 0) (4.11)
As shown in Algorithm 2, the optimal solution to Eq. (4.6) is obtained by iteratively updating P ,
W , S with Eq. (4.8) - Eq. (4.10) until convergence.
Given an example xt, the predicted score for a target disease is PTxt. Let all the k models (i.e.,
each is a P ) be stored in Λ ∈ Rd×k. The prediction function can then be defined as:
f(xt) = Λ
Txt (4.12)
where f : Rd×1 → [−1, 1]k×1.
4.2.4 Personal Health Index Calibration
To convert the predicted scores output by Algorithm 2 into probabilities and allow a person’s PHI to
be comparable to that of others, we further employ a step of PHI calibration.
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First, the scores are z-normalized within the model outputs:
zk =
fk − µk
σk
(4.13)
where fk is the kth score of the output vector, and µk and σk are the mean and standard deviation of
the kth model outputs.
Since those with high risks are in the extreme end of the spectrum, we employ a generalized
extreme value distribution [53]:
G(t) = e−[1−t]
where t indicates the time. Note that it has a steeper growth when t > 0. So the final PHI calibration
function for the kth model outputs is:
Gk(zk) = e
−[1−zk] (4.14)
Finally, the kth score of PHI is the compliment probability:
PHI = 1−Gk(zk) (4.15)
4.3 Experiments and Results
In this section, we report and analyze our experiment results. Extensive experiments were conducted
to evaluate MyPHI using a real-world GHE dataset described in Section 1.2.1. We first discuss how
the 10 disease classes were selected, followed by the experiment setup. Then we analyse and discuss
the results.
4.3.1 Disease Category Grouping
We selected top 10 disease categories that have the highest frequency counts in the GHE dataset based
on the linked Cause of Death (COD) labels encoded in ICD9 and ICD10. Table 4.1 shows the list
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TABLE 4.1: Numbers of positive cases in disease categories
Top k Disease Category Count
1 Lung 649
2 Heart 296
3 Cerebrovascular 153
4 Diabetes 112
5 Stomach 105
6 Colon 101
7 Liver 83
8 Pancreas 61
9 Septicaemia 60
10 Hypertension 42
11 Other 1,314
of those top 10 disease categories. We designed an 11th class called the “Other” category, which
contains all the other health-related ICD codes not in the top 10 disease categories. The sizes of the
11 classes are also shown in Table 4.1.
4.3.2 Experiment Setup
We compared MyPHI with two typical classification methods commonly used in medical applica-
tions as baselines, namely the Support Vector Machines model with linear kernel (LinSVM) and the
Logistic Regression (LR) model. We used LIBSVM [18] for the implementation of LinSVM and
LIBLINEAR [39] for the implementation of LR.
In addition, we compared MyPHI with the class-weighted versions of the baseline methods, de-
noted as LinSVM-W and LR-W respectively, where the class weights were set according to the ratio
of positive and negative class.
We trained a model for each of the 11 disease categories, following the 35:35:30 stratified train/validate/test
split ratio in all experiments. To investigate the effect of class imbalance, the negative (alive) cases
were sub-sampled according to the positive vs. negative ratios 1:1, 1:10 and 1:100. For the “Other”
disease category in the case of 1:100, since the portion of negative size exceeds the total number of
negative cases, we report only the results of 10 disease categories.
The parameters of all the algorithms were searched on the grid of {10−4, 10−2, 1, 102, 104} using
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TABLE 4.2: The averaged AUC (%) of 11 disease categories of various positive vs. negative ratios.
The proposed MyPHI significantly outperforms all the other algorithms in most cases.
Clean Case Noisy Case
Ratio MyPHI LinSVM LinSVM-W LR LR-W MyPHI LinSVM LinSVM-W LR LR-W
1:1 83.48 82.11 82.11 82.79 82.79 74.07 71.23 71.23 70.47 70.47
1:10 85.65 77.99 85.66 78.72 85.19 85.14 75.03 81.56 75.65 80.32
1:100 89.95 68.57 85.91 70.42 85.99 89.37 69.1 83.83 70.45 84.04
the validation set. The parameter θ for chi squared kernel in feature extraction phase was experimen-
tally set to 4.
4.3.3 Results
In this subsection, we analyse our experiment results. We first compare the overall results of all
algorithms in two settings, namely a clean case and a noisy case. Secondly, we look into the perfor-
mance of the prediction on individual disease categories. Then, we investigate the effects of having
the trace-norm in our algorithm. Finally, we show the effects of the length of record sequence on the
performance.
Clean vs. Noisy Cases
The algorithms were firstly evaluated under the ideal situation, where there were only positive in-
stances (i.e., those whose main cause of death is the target disease) and negative instances (i.e., those
who are alive). We call this setting the clean case, as there are no non-target instances to confuse
the learning algorithms. The results are listed on the left of Table 4.2 above using the Area Under
the receiver operating characteristic Curve (AUC) measure under various positive vs. negative ratios
settings. It is clear that MyPHI outperformed all other methods in most cases, and was comparable
with LinSVM-W under 1:10 ratio.
In addition, it can be observed that baseline methods, without considering class-weighting, per-
formed poorly at ratio 1:100. On the other hand, the class-weighted versions of baselines (i.e.,
LinSVM-W and LR-W) was able to better handle class imbalance, though not as good as MyPHI.
In fact, MyPHI achieved its highest performance at 89.95% averaged AUC under 1:100 ratio.
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On the right of Table 4.2, we compare the algorithms in a noisy case, where the non-target in-
stances were introduced by sampling the same amount as the target instances. It can be seen that
the performance was greatly compromised in the case of 1:1 ratio for all algorithms. This shows
that non-target cases did confuse learning models given limited learning instances. However, when
the portion of negative instances increased, the performance bounced back. This may explain how
larger training instances could help mitigate noise. In addition, the gap between MyPHI and other
methods was enlarged in the noisy case. In fact, the performance of LinSVM-W and LR-W dropped
significantly in the noisy case. These results demonstrate the robustness of our method.
Individual Disease Categories
FIGURE 4.2: The AUC for individual disease categories under the 1:100 positive vs. negative ratio.
The top figure shows the performance in the clean case, where no instances of non-target disease
categories are present. The bottom figure displays the performance in the noisy case, where instances
of non-target disease categories are introduced.
We further compared the results at the level of individual disease category. Figure 4.2 shows the
performance of the clean case in the top figure and noisy case in the bottom figure. It can be seen
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FIGURE 4.3: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 1: Lung).
that, although performance varied according to the categories, MyPHI generally outperformed the
other methods. One exception was Hypertension in the clean case; however, our method performed
better in the noisy case. Another exception was Diabetes in the noisy case. For Heart, Cerebrovascu-
lar, Stomach, Colon, Liver, and Hypertension disease categories, MyPHI showed significantly better
results than the other methods.
We looked into the Receiver Operating Characteristic (ROC) curves of the results in individual
disease categories. Figures 4.3 to 4.12 compare the performance of MyPHI, LinSVM-W and LR-W
in the noisy case under 1:100 positive vs. negative ratio. The disease categories are ordered as before
according to their sizes. MyPHI clearly dominated LinSVM-W and LR-W on the ROC graphs in the
cases of Heart, Cerebrovascular, Stomach, Colon, Liver, and Septicaemia categories, while MyPHI
was comparable to the two for Lung, Diabetes, and Pancreas categories.
Effects of trace-norm
We also investigated the effects of introducing the trace-norm constraint onW and P (Eq. 4.5), where
target and alive cases were used to regulate the less certain labels from the non-target cases. As shown
in Figure 4.13 in the Discussion Section 4.3.4, below, introducing W and trace-norm improves the
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FIGURE 4.4: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 2: Heart).
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FIGURE 4.5: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 3: Cerebrovascular).
algorithm’s performance. The effects were more significant in the cases of positive vs. negative ratio
1:1 and 1:100.
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FIGURE 4.6: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 4: Diabetes).
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FIGURE 4.7: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 5: Stomach).
Effects of Record Sequence Length
Studies have shown that the incompleteness of data can degenerate prediction performance [57]. As
discussed in Section 1.2.1, the averaged record sequence length, i.e., number of records per person,
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FIGURE 4.8: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 6: Colon).
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FIGURE 4.9: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 7: Liver).
for our dataset is 2.56, we further conducted experiments to investigate the effects of record sequence
length on the performance.
Figure 4.14 shows the averaged AUC under 1:100 ratio with the 95% confidence limits as the error
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FIGURE 4.10: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 8: Pancreas).
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FIGURE 4.11: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 9: Septicaemia).
bars. The Standard Error of the Mean (SEM) is used to calculate the standard error, i.e., STD/
√
nl,
where STD is the standard deviation and nl is the number of cases with record sequence length l. The
upper and lower confidence limits can be calculated as x¯± 1.96× SEM, where x¯ is the mean AUC.
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FIGURE 4.12: The ROC of the top 10 disease categories under 1:100 positive vs. negative ratio and
noisy settings (Top 10: Hypertension).
FIGURE 4.13: Comparing the effects of applying the trace-norm in averaged AUC: “with W” de-
notes Eq. 4.5 where W is introduced and trace-norm applied, while “w/o W” refers to Eq. 4.4 without
the effect of trace-norm.
Figure 4.14 shows that predictions with five records had the highest averaged AUC, followed by
those with three and four records. Predictions with two records had the lowest averaged AUC score of
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FIGURE 4.14: Comparing the effects of the number of records per person on the performance in
averaged AUC. The error bar is calculated by Standard Error of the Mean (SEM).
84.53%, while the averaged AUC for predictions with six records had a larger SEM due to insufficient
cases in some runs.
4.3.4 Discussion
Label uncertainty is often observed in real-world medical data. Our extensive experiments on a large
GHE dataset with 262,424 check-ups of 102,258 participants have shown the robustness of our model
under label uncertainty and class imbalance.
Specifically, MyPHI achieved its best performance at above 89% averaged AUC under 1:100 ratio,
about 5% higher than LinSVM-W and LR-W (Table 4.2), two de-facto standard classifiers. The best
AUC for a single disease category was achieved in the prediction under the Lung-related disease
category at 96.95% AUC (Figure 4.2). The ROC curves (Figure 4.3 and Figure 4.4) further confirmed
the above analysis at a fine-grained level. These results suggested that the proposed soft-label learning
model is able to better handle label-uncertain data commonly found in medical applications. The
parameter S for soft-labeling allowed the algorithm to learn the degree of certainty for every data
instance based on the data structure.
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In addition, our experiments showed that introducing the terms for W and applying the trace-
norm on E = [W,P ] helped regularize P , with which the performance is improved (Figure 4.13).
This suggested that in dealing with uncertainty, expert knowledge helps.
Finally, we compared the effects of the lengths (2 to 6) of the record sequences on the performance
in Figure 4.14. Predictions based on 5 record sequences had the best performance, while those with
2 records had the worst performance. The corresponding confidence limits based on the computed
mean and standard error can be taken into account along with the predicted PHI given the record
sequence length.
Note that the current model was built based on the GHE dataset, so it is limited to the associated
population, namely the elderly residents of Taipei City. However, the proposed methodology is not
limited to the current dataset, but can be applied to other medical datasets with similar characteristics
as stated in Section 1.2.2. We are also aware of the possible misinterpretation of the predicted results
by non-professionals, which could happen to any screening results [51]. So the understanding and
interpretation of the predicted PHI scores needs to be assisted by a general practitioner.
4.4 Summary
In this chapter we described MyPHI, a data mining-based method that predicts Personal Health Index
(PHI) based on GME records. The extensive experiments on a real-world GME data set of 262,424
records from 102,258 participants demonstrated that our model outperformed the commonly-used
classifiers, such as linear SVM, logistic regression and their class-weighted versions. In particu-
lar, MyPHI has been shown to be robust under label uncertainty and class imbalance, and achieved
89.95% averaged AUC (Area Under the receiver operating characteristic Curve) under a ratio of 1:100
positive vs. negative.
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Chapter 5
Graph-based Health Risk Prediction with
Large Unlabeled Data
5.1 Problems and Challenges
General health examination is an integral part of healthcare in many countries. Identifying the partici-
pants at risk is important for early warning and preventative intervention. In this study we formulated
the task of risk prediction as a multi-class classification problem using the Cause of Death (COD)
information as labels, regarding the health-related death as the “highest risk”. The goal of risk pre-
diction is to effectively classify 1) whether a health examination participant is at risk, and if yes, 2)
predict what the key associated disease category is. In other words, a good risk prediction model
should be able to exclude low-risk situations and clearly identify the high-risk situations that are
related to some specific diseases.
A fundamental challenge is the large amount of unlabeled data. For example, 92.6% of the
102,258 participants in our geriatric health examination dataset (Section 1.2.1) do not have a COD
label. The semantics of such “alive” cases can vary from generally healthy to seriously ill, or any-
where in between. In other words, there is no ground truth available for the “healthy” cases. If we
simply treat this set of alive cases as the negative class, it would be a highly noisy majority class. On
the other hand, if we take this large alive set as genuinely unlabeled, as opposed to cases with known
labels removed, it would become a multi-class learning problem with large unlabeled data.
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FIGURE 5.1: An example of health examination records of participant p1 who took examinations in
three non-consecutive years, 2005, 2007, and 2010. Test items are in different categories (A,B,...) and
the abnormal results are marked black. The main cause of death of p1 was cirrhosis of liver encoded
as K746.
The other key challenge of HERs is heterogeneity. Figure 5.1 above demonstrates the health
examination records of Participant p1 in three non-consecutive years with test items in different cat-
egories (e.g., physical tests, mental tests, etc.) and abnormal results marked black. This example
shows that:
• a participant may have a sequence of irregularly time-stamped longitudinal records, each of
which is likely to be sparse in terms of abnormal results, and
• test items are naturally in categories, each conveying different semantics and possibly con-
tributing differently in risk identification. Therefore this heterogeneity should be respected in
the modeling.
Most existing classification methods on healthcare data do not consider the issue of unlabeled
data. They either have expert-defined low-risk or control classes [47, 121, 90, 125, 75, 96] or simply
treat non-positive cases as negative [113, 22, 102]. Methods that consider unlabeled data [106, 73, 60,
97, 46, 124, 61, 84, 138] are generally based on Semi-Supervised Learning (SSL) [144] that learns
from both labeled and unlabeled data. Amongst these SSL methods, only a few [97, 46] handle large
and genuinely unlabeled health data. However, unlike our scenario, both methods are designed for
binary classification and have predefined negative cases. A closely related approach is Positive and
Unlabeled (PU) learning [83, 130, 131], which can be seen as a special case of SSL with only positive
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labels available. While the unlabeled set U in a PU learning problem is similar to our alive set,
its existing applications in healthcare only address the binary classification problem. Nguyen et al.
introduced a multi-class extension called mPUL [95]; however, their method used a combined set of
negative and unlabeled examples, while in our case negative examples are not available.
This chapter proposes a semi-supervised heterogeneous graph-based algorithm called SHG-Health
(Semi-supervised Heterogeneous Graph on Health) as an evidence-based risk prediction approach to
mining longitudinal health examination records. To deal with the sparsity of health examination
records, it utilizes a graph representation. To handle the heterogeneity of health examination records,
it explores a heterogeneous graph called HeteroHER graph, where examination items in different
categories are modeled as different types of nodes and their temporal relationships as links. To tackle
large unlabeled data, SHG-Health features a semi-supervised learning method that utilizes both la-
beled and unlabeled instances. In addition, it is able to learn an additional K+ 1 “unknown” class for
the participants who do not belong to the K known high-risk disease classes.
The rest of the chapter is organized as follows. Section 5.2 discusses the background on graph-
based semi-supervised learning. Section 5.3 presents the proposed SHG-Health algorithm for evidence-
based risk prediction. In Section 5.4, we demonstrate the effectiveness and efficiency of our proposed
algorithm based on both real datasets and synthetic datasets. Section 5.5 is our summary and findings.
5.2 Background
Learning from labeled and unlabeled data is often called semi-supervised learning or transductive
inference [143]. Graph-based methods that model data points as vertices and their relationships as
edges on graph, are often used to exploit the intrinsic characteristics of data [52]. Zhu et al. [144]
proposed an algorithm based on Gaussian fields and harmonic functions to propagate labels to the
unlabeled data, which can be interpreted as a random walk on graph. Zhou et al. [143] introduced the
Learning with Local and Global Consistency (LLGC) algorithm that spreads the label information of
each point to its neighbors to achieve both local and global consistency.
A graph can be constructed either 1) based on real-world networked data [116, 68, 66], such as
from social networks, bibliographic networks, and web page networks, or 2) by computing affinity
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matrices to encode the similarity between data points [143, 99].
Many graph-based semi-supervised learning (GSSL) methods can be viewed as estimating a func-
tion of soft labels F based on two assumptions on graph [144, 143, 99, 124, 140]. The smoothness as-
sumption states that F should not change much for nearby points, and the fitness assumption requires
that F should not change much from the ground-truth labels. By adapting a graph-based approach and
exploring the underlying graph structure of health examination records with semi-supervised learning,
our method is capable of handling large unlabeled data.
To further tackle the issues of the absence of ground truth for the “healthy” cases and the het-
erogeneity embedded in the examination records, we utilized class discovery methods to handle the
“unknown” class and heterogeneous graph representations for GSSL as follows.
5.2.1 Class Discovery for Graph-based Semi-supervised Learning
Situations arise when unlabeled data may belong to unknown or latent classes. Nie et al. [99] intro-
duced a scholastic graph-based semi-supervised learning (GGSSL) method for novel class discovery
(if the number of classes is known) or outlier detection (if otherwise). By introducing an instance-
level parameter α that assigns small weight to unlabeled data and large weight to the labeled data,
GGSSL allows the soft label scores of unlabeled vertices on the graph to be updated according to
their connectedness to labeled vertices.
Wang et al. [124] further modified the model to discover more than one unseen class for patient
risk stratification based on a patient graph constructed using ICD codes. Recently Zhao et al. [140]
extended GGSSL for classification on Alzheimer’s Disease, by introducing a compact graph con-
struction strategy via minimizing local reconstruction error. However, all of the above algorithms are
limited to homogeneous graphs, where vertices belong to one object type, and thus are by themselves
not capable of handling the data heterogeneity hidden in health examination records.
To train a disease risk prediction model that is capable of identifying high-risk individuals given
no ground truth for “healthy” cases, we treated the “unknown” class as a class to be learned from the
known disease classes. We incorporated the class discovery mechanism of [99] into our method to
handle the “unknown” class.
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5.2.2 Heterogeneous Graph-based Semi-supervised Learning
Traditional GSSL methods have been limited to homogeneous graphs [143, 99, 124, 140]. However,
it has been recognized in recent years that networks of heterogeneous types of objects are prevalent
in the real world [116, 68, 61, 15]. For example in healthcare applications, methods that explore
the heterogeneous structure of gene-phenotype networks have been developed [80, 61]. The term
“network medicine” [15] has been coined to refer to a broad approach to human disease based on a
complex intracellular and intercellular network that connects tissue and organ systems.
For the heterogeneous extensions of GSSL algorithms, Hwang et al. [61] proposed a heteroge-
neous label propagation algorithm based on GSSL for disease gene discovery. Their heterogeneous
disease-gene graph was constructed based on homo-subnetworks that linked same-type objects to-
gether and the mutual interactions between homo-subnetworks. The algorithm iteratively propagates
the label scores via homo-subnetworks and hetero-subnetworks until convergence.
Ji et al. proposed GNetMine [68] to work on a heterogeneous graph of multi-type objects, known
as a heterogeneous information network [116]. This classification process can be intuitively viewed as
a process of knowledge propagation throughout the network across different types of objects through
links. GNetMine was originally designed for bibliographic information networks that were intrinsi-
cally heterogeneous and was shown to outperform other GSSL methods with homogeneous graphs.
They further proposed RankClass [66] based on the same framework with additional updates
on the local weighted graph for individual classes. However, the above methods were designed for a
multi-class semi-supervised learning problem with predefined classes, and thus had no mechanism for
handling the “unknown” class. Inspired by GNetMine and RankClass, we integrated a heterogeneous
component into our method to handle heterogeneity.
In summary, our proposed SHG-Health algorithm can be seen as combining the advantages of
GGSSL [99] and GNetMine [68] for solving a practical clinical problem of risk prediction from
longitudinal health examination data with heterogeneity and large unlabeled data issues.
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FIGURE 5.2: An overview of the proposed SHG-Health algorithm for risk prediction
5.3 SHG-Health: a Semi-supervised Heterogeneous Graph-based
Algorithm for Health Risk Prediction
To solve the problem of health risk prediction based on health examination records with heterogeneity
and large unlabeled data issues, we present a semi-supervised heterogeneous graph-based algorithm
called SHG-Health. The semi-supervised learning problem is formulated as follows:
Problem 5.1. Given a set of health examination records of n participants S = {s1, ..., sl, sl+1, ..., sn},
where si = {ri1, ..., rini} is the set of ni records of participant pi and rij is a tuple (xij, tij) such that
xij ∈ Rd is a d-dimensional vector for the observations at time tij , and a set of labels C = {1, ..., c},
the first l participants si (i ≤ l) are labeled as yi ∈ C and the remaining u = n − l participants
sl+1, ..., sl+u are unlabeled (l  u). The goal is to predict for unlabeled si(l < i ≤ n) a label
yi ∈ C˜ = {1, ..., c, c+ 1} where c+ 1 gives a mechanism to handle an additional class for unknown
cases.
An overview of our proposed solution to the problem is included in Figure 5.2, above. Our SHG-
Health algorithm takes General Health Examination data (GHE) and the linked Cause of Death (COD)
labels described in Section 1.2.1 as inputs. Its key components are a process of Heterogeneous Health
Examination Record (HeteroHER) graph construction and a semi-supervised learning mechanism
with label propagation for model training. Given the records of a participant pi as a query, SHG-
Health predicts whether pi falls into any of the high-risk disease categories or “unknown” class whose
instances do not share the key traits of the known instances belonging to a high-risk disease class.
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5.3.1 HeteroHER Graph
A graph representation allows us to model data that is sparse. It is useful for modeling data such as
our GHE records, where abnormal results are of interest. To capture the heterogeneity naturally found
in health examination items, we constructed a graph called HeteroHER consisting of multi-type nodes
based on health examination records.
Graph Construction
The process of HeteroHER graph construction included the following steps:
Step 1. Binarization:
As a preparatory step, all the record values were first discretized and converted into a 0/1 binary
representation, which served as a vector of indicators for the absence/presence of a discretized value.
Specifically, real values, such as age, were first binned into fixed intervals (e.g., 5 years). Then, all
the ordinal and categorical values were converted into binary representations.
Step 2. Node Insertion:
Every element in the binary representation obtained in Step 1 with a value “1” was modeled as a
node in our HeteroHER graph, except that only the abnormal results were modeled for examination
items (both physical and mental). This setting was primarily based on the observation that physi-
cians make clinical judgements generally based on the reported symptoms and observed signs, and
secondarily for the reduction of graph density.
Step 3. Node Typing:
Every node was typed according to the examination category that its original value belonged to,
for example, the Physical tests (A), Mental tests (B), and Profile (C) in Figure 5.1. In addition, a new
type of nodes was introduced to represent individual records such as r11, r12, and r13 in the same
figure.
All the other non-Record type nodes that were linked to the Record type nodes could be seen as
the attribute nodes of these Record type nodes. In other words, categories A, B, and C in Figure 5.1
could be regarded as the attributes of the Record type at a schema level. This leads to a graph schema
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with a star shape as shown on the right of Figure 5.3, which is known as a star schema [116]. Note
that types can often be hierarchically structured and thus choosing the granularity of node type may
require domain knowledge or be done experimentally.
Step 4. Link Insertion:
Every attribute (non-Record) type node was then linked to a Record type node representing the
record that the observation was originally from. The weight of the links was calculated based on the
assumption that the newer a record the more important it was in terms of risk prediction. A simple
function g(·) can be defined as:
g(t) =
t− s+ 1
1
(5.1)
where t is the time of current record, l is the time window of interest, and s is the starting time of the
time window.
Other functions such as truncated Gaussian distribution and Chi Squared distribution could also
be used [23]. The window length can be selected according to the application needs. For example,
the time unit for our risk prediction is in years and the window length was set as 6 years.
We included Figure 5.3 as an example based on the records of participant p1 in Figure 5.1 to
illustrate the process. In this simplified example, we assumed all the values of examination items were
binary. Different types of examination items in Figure 5.1 were treated as different types of nodes
on the graph. An abnormal result of the ith item of type Z in the jth record of the kth participant is
represented as a link between nodes rkj and zi. For instance, there is a link between r11 and a3 in the
left sub-figure of Figure 5.3, and the weight of the link is (2005−2005 + 1)/6 ∼= 0.17 using Eq. (5.1)
with a window width equal to 6 years.
The output of the graph construction process was a heterogeneous graph represented as a set W
of sparse matrices Wij for any two node types i, j that are linked to each other in the schema on the
right in Figure 5.3.
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FIGURE 5.3: The graph on the left shows a HeteroHER graph extracted from the example in Figure
5.1. For instance, there is a link between r11 (the first record of p1) and a3 (the third item of category
A) if the result of a3 is abnormal in r11. The link is weighted using Eq. (5.1). The star-shaped schema
on the right is a type-level schema of such a graph.
Normalized Weights
To strengthen the weights in the low density region and weaken the weights in the high density region,
the weights Wij for i, j = 1, ...,m were further normalized by the row sum and column sum as in
[99]:
W˜ij = D
−1/2
ij WijD
−1/2
ji (5.2)
where Dij is an ni-by-ni diagonal matrix with the (p, p) element as dij,pp and dij,pp =
∑
qWij,pq is
the sum of row p in Wij .
5.3.2 Semi-supervised Learning on HeteroHER Graph
The second component of our method was a semi-supervised learning algorithm for the constructed
HeteroHER graph (Section 5.3.1). The algorithm combines the advantages of [99] for class discov-
ery and [68] for handling heterogeneity to solve a specific problem induced by evidence-based risk
prediction from health examination records.
In this section, we first define an objective function for the learning problem and show its convex-
ity, followed by an optimization procedure to solve the problem. Then we derive an efficient iterative
algorithm and show its convergence. Finally, time complexity is discussed.
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Notations
Let us start with definitions and notations for the following discussions. Assume there are c classes
and there is one additional “unknown” class for the cases that are not known to belong to any of the
c disease classes. In this work we attach label information of a participant to the Record type nodes
representing their examination records. However, the model is general enough to include labels for
different types of nodes.
Defining Y = [Y1, ..., Ym]T ∈ {0, 1}
∑m
i ni×(c+1) such that Yi = [yi1, ..., yini ]
T ∈ {0, 1}ni×(c+1)
encodes the labels of type i nodes. Let y(k)ip be the k
th element of vector yip. If xip, i.e., node p of type
i, is labeled, y(k)ip = 1 if xip belongs to class k; otherwise y
(k)
ip = 0. If xip is unlabeled, y
(c+1)
ip = 1.
By doing so, we set the initial labels of the unlabeled data to be the unknown class. However, we
will show later (Section 5.3.3) that these initial labels for the unlabeled data have little influence on
learning their labels.
In addition, we designed the computed labels to be soft labels. Soft labels are especially desirable
for medical applications because they provide a level of confidence for the prediction. Let F =
[F1, ..., Fm]
T ∈ R∑mi ni×(c+1) be the computed soft labels of m node types such that Fip ∈ Rc+1 is a
vector indicating the degree of certainty that xip belongs to any of the c + 1 classes. The class label
of xip is computed as:
arg max
k≤(c+1)
F
(k)
ip
and Fi can be initialized uniformly amongst type i nodes for i = 1, ...,m.
Objective Function
We considered a regularized framework on a heterogeneous graph for our problem, denoting tr(·) as
trace and ‖·‖F as the Frobenius norm of matrix, i.e., ‖M‖2F = tr(MTM). The classification problem
can then be viewed as an optimization problem that minimizes an objective function J(F ):
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J(F ) =
m∑
ij
γij
ni∑
p
nj∑
q
W˜ij,pq ‖Fip − Fjq‖2F
+
m∑
i
ni∑
p
µipd˜ip ‖Fip − Yip‖2F
(5.3)
where W˜ij is the normalized weights on the links between type i and j nodes as defined in Eq. (5.2),
above, and F and Y are the same as defined earlier.
The first term is the smoothness constraint based on the assumption that if two nodes in a graph
are close to each other, their computed label values should be close. Let z = [z1, ..., zm]
T where
0 ≤ zi ≤ 1 be the weights for m node types. Then, γij is defined as between-type weight of type i
and type j nodes as follows:
γij =

1
2
zj if i = j
zj otherwise
(5.4)
where the weight is reduced to half for links between same-type nodes to avoid double counting
in the summation.
The second term is the fitness constraint that penalizes when the computed F is different from
labels Y . Let d˜ij,pp =
∑
q W˜ij,pq and D˜ij be an ni-by-ni diagonal matrix with the (p, p) element as
d˜ij,pp. Then d˜ip in Eq. (5.3) is the degree of node p of type i, weighted by its connected node type, i.e.,
d˜ip =
∑m
j
∑ni
p zjD˜ij,pp. On the other hand, µip > 0 controls the trade-off between the smoothness
and fitness constraints for node p of type i.
Convexity
The strict convexity of Eq. (5.3) minimization is derived in this section. For clarity, we will discuss
two terms in Eq. (5.3) separately. The first term of the objective function denoted as J1(F ) can be
92 GRAPH-BASED HEALTH RISK PREDICTION WITH LARGE UNLABELED DATA
derived as follows:
J1(F ) =
m∑
i
(
m∑
j
γij
ni∑
p
nj∑
q
W˜ij,pq ‖Fip − Fjq‖2F )
=
m∑
i
m∑
j
γijtr(F
T
i D˜ijFi − 2F Ti W˜ijFj + F Tj D˜jiFi)
= tr(
m∑
i
m∑
i 6=j
zj(F
T
i D˜ijFi − 2F Ti W˜ijFj + F Tj D˜jiFi)
+ ziF
T
i (D˜ii − W˜ii)Fi)
(5.5)
where W˜ij is defined in the same way as in Eq. (5.2) and D˜ij and γij the same as in Eq. (5.3).
Suppose the total number of nodes n =
∑m
i ni. Let L˜ be a n-by-n block matrix. Let its (i, j)
block L˜ij = D˜ij − W˜ij be a Laplacian matrix with normalized weights. Eq. (5.5) can be transformed
to the following matrix expression:
J1(F ) = tr(F
T IzL˜F ) = tr(F
THF ) (5.6)
where Iz is a block diagonal matrix with the elements of the diagonal of (i, i) block equal to zi, and
H = IzL˜.
The second term of the objective function can be derived as follows:
J2(F ) =
m∑
i
ni∑
p
µipd˜ip ‖Fip − Yip‖2F
= tr(
m∑
i
(Fi − Yi)TUiD˜i(Fi − Yi))
(5.7)
where the diagonal matrix D˜i =
∑m
j zjD˜ij and its (p, p) entry is d˜ip as defined earlier in Section
5.3.2. Ui is a diagonal matrix such that Ui,pp = µip.
Combining Eq. (5.6) and Eq. (5.7), the objective function can be transformed into:
J(F ) = tr(F THF ) + tr((F − Y )TUD˜(F − Y )) (5.8)
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where D˜ is a block diagonal matrix with the diagonal of the (i, i) block equal to D˜i.
It is easy to verify that L˜ is positive semi-definite and likewise, H , U , D˜, UD˜ and their traces.
Therefore the objective function is strictly convex.
Optimization Procedure
The closed-form solution for minimizing Eq. (5.8) can be obtained by setting the partial derivative of
J(F ) with respect to F to zero:
∂J(F )
∂F
∣∣∣∣
F=F ∗
= 2(HF ∗ + D˜U(F ∗ − Y )) = 0 (5.9)
where we use the fact that H = IzL˜ is symmetrical and that D˜ and U are diagonal.
By multiplying D˜−1 on both sides of Eq. (5.9) and rearranging the equation, we have:
F ∗ = (D˜−1IzL˜+ U)−1UY (5.10)
By using the fact that U = I−Iα
Iα
=
Iβ
Iα
, we have:
F ∗ = (D˜−1IzL˜Iα + Iβ)−1IβY
= (Iα(I − IzP ) + Iβ)−1IβY
= (I − IαIzP )−1IβY
= (I − Pˆ )−1IβY
(5.11)
where L˜ = D˜ − W˜ as before, P = D˜−1W˜ , and Pˆ = IαIzP .
Note that the ∞−norm of IαIzP is lower than 1 given 0 ≤ ziαi < 1(i = 1, ..., n). Hence the
spectral radius of Pˆ is not greater than the∞−norm. So (I − Pˆ ) is invertible.
5.3.3 Iterative Solution
An iterative algorithm is often more efficient than a closed-form solution with the inverse of a matrix.
Here we describe an iterative solution for F and prove its convergence. The optimal Fi for type i
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nodes can be computed with the following update rule for i = 1, ...,m:
Fi(t+ 1) = Iαi
m∑
j
zjPijFj(t) + IβiYi (5.12)
where Pij = D˜iW˜ij , Iβi = I − Iαi , and zj is a type weight scalar as defined earlier in Section 5.3.2.
Eq. (5.12) bears a label propagation interpretation. Each node iteratively spreads label information
to its neighbors until a global stable state is achieved. Particularly, zjPij can be seen as the normalized
links from type j nodes to type i nodes, scaled by the source type weight zj . Soft labels of type i nodes
at (t + 1) are determined by two factors, 1) the computed label scores of neighboring nodes at time
t propagated via links, and 2) the initial labels for type i nodes. The diagonal matrix Iαi controls the
trade-off between these two influences.
It is important to note that Iαi provides a mechanism to learn an extra outlier class via an instance-
level control over the trade-off. Specifically, αl and αu are introduced as parameters in the range of
[0, 1] that control the influence from the labeled data and unlabeled data respectively.
The parameters αip (p = 1, ..., ni) in Iαi are defined as αip = αl if xip is labeled, and αip = αu if
otherwise. The larger αl and αu are, the less influence initial labels from Y has. Particularly, when αu
is set to a value extremely close to 1, it means that the initial labels of the unlabeled data play almost
no role in the learning so that the computed label for an unlabeled case is basically determined by its
connectivity in the graph. This mechanism allows the algorithm to learn an additional (c + 1) class
for nodes that are less connected to the labeled nodes from high risk disease classes.
The complete algorithm of SHG-Health, combining the graph construction and iterative solution,
is summarized in Algorithm 3.
Convergence
The proof of the convergence of Eq. (5.12) is as follows: Let Iα, Iβ , zj and P = Dˆ−1Wˆ be the same
as defined earlier in Section 5.3.2. The update rule Eq. (5.12) for type i = 1, ...,m can be reorganized
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Algorithm 3 SHG-Health
Input: a set of health examination records of n participants S, the corresponding encoded labels Y
Output: optimized F as the computed soft labels
1: W ← graph construction from S (Section 5.3.1).
2: Calculate the normalized weights for i, j = 1, ...,m by: W˜ij = D
−1/2
ij WijD
−1/2
ji (5.2)
3: Initialize Fi uniformly amongst type i nodes for i = 1, ...,m.
4: t = 1
5: repeat
6: Update Fi for i = 1, ...,m by:
7: Fi(t+ 1) = Iαi
m∑
j
zjPijFj(t) + IβiYi (5.12)
8: t = t+ 1
9: until convergence return F
as:
Fi(t+ 1) = Iαi
m∑
j
zjPijFj(t) + IβiYi
= IαiPiIziF (t) + IβiYi
= PˆiF (t) + IβiYi
(5.13)
where Pˆi = IziIαiPi. It is equivalent to the following expression:
F (t+ 1) = PˆF (t) + IβY (5.14)
It has been proven in [99] that F ∗ = lim
t→∞
F (t) = (I − Pˆ )−1IβY , which is equivalent to the close-form
solution expressed in Eq. (5.11), and hence our proof is completed.
Time Complexity Analysis
Now we analyze the computational time complexity of the iterative solution (Step 3-8 of Algorithm
3). Step 3 takes O(k|V |) time for initialization, where k is the number of classes (i.e., k = c+ 1) and
|V | is the number of nodes in the graph. At each iteration of Step 6, every link needs to be processed
twice, once for the node at each end of the link. This is done for every class, and consequently
takes O(k|E|) time, where |E| is the number of links. Also, another O(k|V |) time is needed for
incorporating IβiYi. Therefore, the total time for each iteration is O(k(|E|+ |V |)), and the total time
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complexity for the entire iterative solution is O(lk(|E|+ |V |)), where l is the number of iterations.
5.4 Experiments and Results Analysis
Synthetic Datasets
To test the stability of our method, we generated two groups of synthetic datasets based on the dis-
tribution of the processed real datasets. Specifically, we computed the value distributions for a given
disease class, a given year, and a given feature for 10 disease classes selected based on COD codes.
The selection of these disease classes is reported in Section 5.4.1.
The cumulative distribution functions (CDFs) were computed, based on which a random number
generator was used to select a value for a given disease class, a year, and a feature. The resulting
synthetic datasets are as follow.
• Balanced datasets. To test the stability with increasing class size in a balanced-class setting, we
generated the same number of instances for all disease classes and the “unknown” (unlabeled)
class with increasing class size in the range of {100, 300, 500, 1000}.
• Increasing unlabeled size datasets. To test the stability, given the increasing scale of unlabeled
data, we generated 1000 instances for every disease class, with the “unknown” (unlabeled) class
size equivalent to 1000× p, where p is a scalar in the range of {1, 3, 5, 10, 15, 20}.
Note that the synthetic datasets were generated based on the assumption that features were indepen-
dent, which does not hold in real-world healthcare data. However, by using synthetic datasets we
could better understand algorithm behaviors in different class settings.
5.4.1 Experimental Settings
High-risk Disease Classes
We selected 10 ICD disease categories as high-risk disease classes. The first 3 digits of ICD 10
were used to define disease categories and mapped to the corresponding 3-digit ICD 9 codes for the
5.4 EXPERIMENTS AND RESULTS ANALYSIS 97
TABLE 5.1: Sizes of 10 disease categories and unlabeled cases in terms of participant (P) and record
(R).
Class ICD10 Name ICD9 Size (P) Size (R)
1 J18 Pneumonia, organism unspecified 481,485,486,514 434 851
2 J40-J44 Chronic lower respiratory diseases 490-493,496 277 531
3 C34 Malignant neoplasm of bronchus and lung 162 253 586
4 C22 Malignant neoplasm of liver and intrahepatic bile ducts 155 219 375
5 C16 Malignant neoplasm of Stomach 151 193 355
6 C18 Malignant neoplasm of colon 153 186 371
7 I25 Chronic ischaemic heart disease 412,414,429 185 330
8 C25 Malignant neoplasm of pancreas 157 123 242
9 C23 Malignant neoplasm of gallbladder 156 74 126
10 G20 Parkinson’s disease 332 37 73
Unlabeled (alive) cases 26,771 69,802
records taken before 2009. Table 5.1, shows the size of the 10 disease classes in terms of the number
of participants and number of records.
The process of selecting 10 disease categories is as follows. We selected diseases with top-10
frequency counts. Based on suggestions from clinical experts, we excluded diabetes mellitus, which
was known to have many complications, and acute myocardial infarction, an acute disease. This gave
us the first 8 classes in Table 5.1.
To make the problem closer to a real-world situation, we selected two additional diseases with
less frequency to represent minority classes. The unlabeled cases were then randomly selected from
the alive cases with a ratio equal to data distribution i.e., the deceased/alive ratio as 7.4/92.6. This
gave us 69,802 records from 26,771 unlabeled participants (Table 5.1).
HeteroHER Graph Construction
Four node types were modeled for constructing our HeteroHER graph, namely Record, Physical Test,
Mental Test, and Profile. Physical Test refers to all the lab tests and physical examinations in Table
1.1 introduced earlier in Chapter 1, while Mental Test covers both the mental health assessments and
cognitive function assessments. Profile includes all the patient demographics and habits, and Record
indicates the artificial nodes created for representing individual records. As discussed earlier, only the
abnormal results, both from physical and mental tests, were included in graph construction.
Table 5.2 shows the network statistics of the HeteroHER graphs extracted from both the real and
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TABLE 5.2: Extracted HeteroHER graph statistics
Dataset # participant
# nodes # links to Record nodes
Density
Record Total Test Mental Profile Total
Real GHE@10class 26,771 73,642 73,778 601,062 119,952 523,387 1,244,401 0.1242
Synthetic
(100,100) 1,100 3,013 3,149 28,071 4,611 22,552 55,234 0.1348
(300,300) 3,300 9,054 9,190 84,052 13,982 68,053 166,087 0.1349
(500,500) 5,500 15,092 15,228 139,736 23,134 113,231 276,101 0.1345
(1000,1000) 11,000 30,201 30,337 280,412 46,655 227,932 554,999 0.1351
(1000,3000) 13,000 35,463 35,599 323,101 55,263 265,067 643,431 0.1334
(1000,5000) 15,000 40,695 40,831 365,005 63,974 301,661 730,640 0.1320
(1000,10000) 20,000 53,674 53,810 469,575 85,167 393,486 948,228 0.1299
(1000,15000) 25,000 66,841 66,977 575,360 106,694 485,914 1,167,968 0.1285
(1000,20000) 30,000 79,979 80,115 682,022 128,357 579,269 1,389,648 0.1278
synthetic datasets. Note that density was calculated as the ratio of the number of edges E to the
number of possible edges P . Since HeteroHER Graph has a star schema (Figure 5.3), P is calculated
as the number of Records nodes times the number of all attribute type nodes.
Evaluation Metrics
We designed a two-stage evaluation strategy to evaluate the proposed SHG-Health.
In the first stage, we evaluated an algorithm’s ability to identify high-risk cases, regardless of
their disease category. All predicted disease cases were regarded as predicted positive cases and
the true disease cases were regarded as (true) positive cases. As there was no ground truth for the
negative or healthy cases, we used measures that focused on positive predictions, namely precision,
recall/sensitivity, and F-score. While precision measures how accurate the positive predictions of an
algorithm are, recall shows its ability to catch the positive cases. F-score calculates the harmonic
mean between precision and recall.
In the second stage, we looked into a method’s ability to predict the correct disease class given
that it predicted a case to be in one of the high-risk classes. This was a conditional evaluation that only
considered cases that were predicted as one of the disease classes. Macro-precision and macro-recall
measures were used. Macro-averaging took the average of precision or recall scores computed from
individual classes [79]. It assumed that all classes were equally important, so that the performance of
minority classes could be reflected in the macro-averaged scores.
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Algorithms for Comparison
For SHG-Health, we compared three time-weighted functions for graph construction, namely Eq.
(5.1) (SHG-Health), truncated Gaussian (SHG-Health-Gaus), and truncated Chi Squared (SHG-Health-
Chi2) discussed in Section 5.3.1. Other algorithms that were compared with our method were:
• Support Vector Machines: SVM was adopted as one of our baseline methods. Although SVM
with RBF kernel achieved the best results in [22], linear and RBF kernels had very similar per-
formance in our experiments. We only report the results of the linear kernel for its favourable
efficiency. The LIBSVM [18] and LIBLINEAR [39] implementations were used in our experi-
ments for the RBF and linear kernels respectively.
• Nearest Neighbor Classifier: KNN classifier is a common baseline for graph-based models.
K was experimentally set to 1.
• General Graph-based Semi-Supervised Learning: GGSSL [99] is a state-of-the-art graph-
based semi-supervised method for class discovery. As it is not directly applicable to hetero-
geneous graphs, we constructed a homogeneous graph by converting all types of nodes in our
heterogeneous graph into a single-type graph. The MATLAB implementation available from
the author web page [98] was employed in our experiments.
• GNetMine: GNetMine [68] is a state-of-the-art graph-based semi-supervised method on a
graph of heterogeneous nodes. The MATLAB implementations by the authors, available from
GitHub [65], was employed in our experiments.
For parameter tuning, the parameters c and γ for SVM were tuned based on the {10−4, 10−2, 1, 102, 104}
grid. The parameters αi and λij in GNetMine denote type weights and type relationship weights re-
spectively. They were tuned based on the αi/λij ratio grid {0.01, 0.05, 0.1, 0.5, 1, 5, 10} with αi fixed
to 0.1 as in [68]. For fair comparison to GNetMine, the type weight parameters zj (j = 1, ...,m) of
SHG-Health were also set uniformly. The parameters αl and αu that control the influence from Y for
the labeled and the unlabeled data respectively, were set to 0.01 for αl as in [99] and tuned based on
the grid {0.9, 0.99, 0.999, 0.9999, 0.99999} for both SHG-Health and GGSSL methods.
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TABLE 5.3: Evaluation on binary prediction (avg±std%)
Precision Recall/Sensitivity F-Score
SHG-Health 96.24 ± 1.60 43.93 ± 1.11 60.32 ± 1.23
SHG-Health-Chi2 99.33 ± 0.36 43.02 ± 1.40 60.02 ± 1.41
SHG-Health-Gaus 96.99 ± 1.32 43.69 ± 1.14 60.23 ± 0.86
SVM 89.00 ± 10.19 0.49 ± 0.36 0.98 ± 0.71
KNN 37.52 ± 1.48 25.62 ± 1.30 30.45 ± 1.36
GNetMine 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
GGSSL 5.21 ± 0.02 100.00 ± 0.00 9.91 ± 0.03
All of the experiments were conducted using 5-fold stratified cross validation. The performance
on the testing set was obtained by averaging over 5-fold results. All the experiments were run on an
Intel(R) Core(TM) CPU@3.40GHz workstation with 16GB physical memory.
5.4.2 Result Analysis
In this section we report and analyze the experimental results. The best λij, ∀i, j ∈ {1, ...,m} for
GNetMine was 0.2 in all of our experiments, the same as reported in [68]. The best αu for SHG-Health
was 0.99, while GGSSL tended to bias toward one disease class with αu = 0.9999 and completely
toward the unknown class with αu less than that.
Identifying High-risk Cases
In this first stage of the two-stage evaluation (Section 5.4.1), we compared algorithms based on their
abilities to identify high-risk cases regardless of what disease category they belonged to. All of the
cases from different high-risk disease classes were regarded as belonging to one class, i.e., the high-
risk class. This binary setting evaluated how well an algorithm was able to pick up high-risk cases in
general.
Table 5.3, above, shows that our algorithms achieved the best overall performance at 99.33% pre-
cision (SHG-Health-Chi2), 43.93% recall (SHG-Health), and 60.32% F score (SHG-Health). GGSSL
had 100.00% recall but extremely low precision at 5.21%, which indicates that it leaned towards pre-
dicting most cases as high-risk. On the other hand, GNetMine was completely biased toward the
“unknown” class and thus had zero precision, recall, and F scores. The fact that recall scores for
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TABLE 5.4: Evaluation on disease class prediction (avg±std%)
Macro-Precision Macro-Recall
SHG-Health 89.14 ± 0.56 89.62 ± 0.38
SHG-Health-Chi2 90.58 ± 0.19 90.73 ± 0.15
SHG-Health-Gaus 89.55 ± 0.56 90.30 ± 0.41
KNN 21.12 ± 1.49 59.92 ± 2.50
SVM 52.50 ± 39.41 63.33 ± 30.55
GNetMine - -
GGSSL 0.11 ± 0 9.09 ± 0
all methods were less than 50% also shows that capturing positive cases from large and noisy unla-
beled cases was difficult. Our proposed SHG-Health could be seen as a conservative model, which is
desirable for a preventive care system because the cost of false alarms is high [86, 63].
Classifying into Correct Disease Categories
In the second stage, we further evaluate the algorithms’ conditional performance on multi-class clas-
sification. This is to evaluate the accuracy of disease-level predictions, given that the cases had been
predicted into one of the disease classes. The macro-averaging measures were used to evaluate how
correct these predictions were at the disease category level. Note that any “alive” case incorrectly
predicted as one of the disease classes was counted as an incorrect prediction in this calculation.
Table 5.4 shows that our SHG-Health, especially SHG-Health-Chi2, outperformed all the other
algorithms, achieving 90.58% macro-precision and 90.73% macro-recall. Overall, our algorithm was
able to classify high-risk individuals into a correct disease category quite accurately.
Top Scored Test Items
Based on the COD labels available for the record type nodes, SHG-Health also computed scores as
soft labels for other types of nodes, such as the Physical Test nodes. Within-class scores of a node
type can reveal the relative importance of those nodes in the class.
Top-5 scored Physical Test items for 10 disease classes are listed in Table 5.5. There were some
interesting results identified by our clinical experts. For example, for lung related disease categories,
namely pneumonia, chronic lower respiratory diseases, and malignant neoplasm of bronchus and
lung, chest examination had the highest score. This bears the interpretation that participants with
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TABLE 5.5: Top 5 scored test items for 10 disease classes
Top 5 1) Pneumonia, organism unspecified 2) Chronic lower respiratory diseases 3) Malignant neoplasm of bronchus and
lung
1 Chest Exam Chest Exam Chest Exam
2 Albumin Urinary casts Alpha-Fetoprotein
3 Urinary casts Albumin Hemoglobin
4 Hemoglobin Hemoglobin Hematocrit
5 Blood urea nitrogen (BUN) Alpha-Fetoprotein Mean corpuscular volume
Top 5 4) Malignant neoplasm of liver and intra-
hepatic bile ducts
5) Malignant neoplasm of Stomach 6) Malignant neoplasm of colon
1 Alpha-Fetoprotein Albumin Albumin
2 Aspartate Aminotransferase (GOT) Hemoglobin Alpha-Fetoprotein
3 Glutamic-Pyruvic Transaminase (GPT) Mean corpuscular volume Chest
4 Platelet count Platelet count Hemoglobin
5 Glucose urine test Hematocrit Creatinine blood test
Top 5 7) Chronic ischaemic heart disease 8) Malignant neoplasm of pancreas 9) Malignant neoplasm of gallblad-
der
1 Creatinine blood test Glucose urine test Alpha-Fetoprotein
2 Blood urea nitrogen (BUN) Albumin Aspartate Aminotransferase (GOT)
3 Glucose urine test Mean corpuscular volume Chest
4 Protein in Urine (Proteinuria) Alpha-Fetoprotein Mean corpuscular volume
5 Hemoglobin Pus Cell in Urine Red blood cell count
Top 5 10) Parkinson’s disease
1 Urinary casts
2 Chest
3 Hemoglobin
4 Albumin
Red blood cell count
these diseases commonly have abnormal chest examination results. Another obvious example can
be found in the malignant neoplasm of liver and intrahepatic bile ducts class. Top-1 ranked item
Alpha-Fetoprotein is a commonly used tumor marker for liver cancer. GOT and GPT are the enzymes
concentrated in the liver, commonly used as key indicators for evaluating liver damage.
These results show that SHG-Health was able to identify important examination items for disease
classes. By modeling features (i.e., examination items) as different types of nodes on a graph, the
computing of soft labels for these nodes is actually a mechanism of feature weighting. It is the
connection to these highly scored features of a class that determines the class label of a Record node
in the graph.
Stability on Synthetic Data
We further compared the stability of the algorithms using two groups of synthetic data generated
based on the distribution of the real data. The first group was the balanced datasets with increasing
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size per class in the range of {100, 300, 500, 1000}. The second group contained the datasets with
increasing number of unlabeled cases in the scale of {1, 3, 5, 10, 15, 20} times of the size of a labeled
class. For the details on how these datasets were generated, please refer to Section 5.4. We evaluated
algorithms in terms of their ability to identify high-risk cases (Task 1) and their ability to classify a
high-risk case into the correct disease class (Task 2). The same measures as in the real dataset case
were used. It suffices to report the F scores for Task 1 and macro-averaging scores for Task 2.
Figures 5.4 to 5.8 below show the results from the balanced synthetic datasets. It can be seen
from the F scores that all the algorithms performed stably in Task 1 except that 1NN had lower
scores when class sizes were small. Our method was comparable to SVM and they had the highest
performance in Task 1 (Figure 5.4 to Figure 5.6). However, our algorithm achieved significantly
better macro-precision and macro-recall scores than the other algorithms in Task 2 (Figure 5.7 to
Figure 5.8). While our SHG-Health stably maintained 70% macro-precision, others fluctuated below
50%. A similar phenomenon can be observed in the case of macro-recall.
We expected the performance would drop with the increasing scales of unlabeled data as shown
in Figure 5.9 to Figure 5.11. The F scores of Task 1 confirm this intuition in Figure 5.11. The 1NN,
GNetMine, and GGSSL methods had a steeper descending gradient than SVM and our approach, as
the size of the unlabeled cases increased from 1,000 to 20,000. However, when it came to predicting
correct disease classes (Task 2), as shown in Figure 5.12 and Figure 5.13, our SHG-Health had the
highest macro-precision and macro-recall scores on the synthetic datasets. Note that the performance
of our method went up as the unlabeled sizes increased from 10,000 to 20,000. It could be that
more unlabeled cases helped our method to differentiate between disease classes better. It is worth
mentioning that SVM had the most stable performance in Task 2, slightly below 50% for both macro-
averaging measures.
Time Analysis
To investigate the scalability of all the algorithms, we recorded the training time for experiments on
the synthetic datasets (Chapter 5.4.2), except that the testing time of 1NN was recorded. Figure 5.14,
below, compares the time performance of all the algorithms with increasing data sizes. It can be
seen that our method was the most time-efficient method of all, with only 1.41 seconds of training
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FIGURE 5.4: Task 1 results of the synthetic datasets with increasing unlabeled cases (Precision).
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FIGURE 5.5: Task 1 results of the synthetic datasets with increasing unlabeled cases (Recall).
time at (1000, 20000), i.e., 10×1000=10,000 disease cases plus 20,000 unlabeled cases. Note that
the implementations we used for other methods are either standard implementations (SVM and 1NN)
or from the author provided codes (GNetMine and GGSSL) and they might not be best tuned for
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FIGURE 5.6: Task 1 results of the synthetic datasets with increasing unlabeled cases (F Score).
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FIGURE 5.7: Task 2 results of the balanced synthetic datasets with increasing class sizes (Macro-
precision).
efficiency. The purpose of Figure 5.14 is to show that our approach also enjoys desirable efficiency
given its superior effectiveness as demonstrated in previous sections.
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FIGURE 5.8: Task 2 results of the balanced synthetic datasets with increasing class sizes (Macro-
recall).
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FIGURE 5.9: Task 1 results of the synthetic datasets with increasing unlabeled cases (Precision).
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FIGURE 5.10: Task 1 results of the synthetic datasets with increasing unlabeled cases (Recall).
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FIGURE 5.11: Task 1 results of the synthetic datasets with increasing unlabeled cases (F score).
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FIGURE 5.12: Task 2 results of the synthetic datasets with increasing unlabeled cases (Macro-
precision).
5.4.3 Discussion
The experimental results showed that SHG-Health performed the best amongst all the algorithms
compared. Particularly, its ability 1) to identify high-risk cases and 2) to predict the correct disease
category for high-risk cases has been demonstrated and verified on our real datasets (Chapter 1.2.1)
and synthetic datasets (Section 5.4).
From the results of real datasets reported in Table 5.3 and Table 5.4, we could see that although
GNetMine also utilizes a heterogeneous network structure for classification, it tended to be biased
toward the noisy “unknown” class. The reason is that GNetMine does not have a mechanism to
control the label influence at instance level, such as the α parameters (Section 5.3.3) in our method
and in GGSSL, nor the ability for class discovery. On the other hand, although GGSSL had such a
mechanism, a homogeneous graph construction misses out the type-specific information that can help
the classification. As a result, GGSSL was completely biased toward the dominant disease class.
In the case of synthetic datasets, the performance for most methods dropped in Task 2 (Figure
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FIGURE 5.13: Task 2 results of the synthetic datasets with increasing unlabeled cases (Macro-
recall).
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FIGURE 5.14: Computational time analysis on the synthetic datasets for the algorithms compared.
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5.7 to Figure 5.8 and Figure 5.12 to Figure 5.13). This can be explained by the information lost due
to the feature independence assumption for generating the synthetic datasets. The exceptions were
GNetMine and GGSSL, which showed more reasonable performance on synthetic datasets. It could
be that they were better in handling independent features than correlated ones. The efficiency of our
method has also been demonstrated in Figure 5.14 based on the same synthetic datasets.
The above analysis demonstrated that our proposed SHG-Health is superior because it has the
ability to handle the heterogeneity and large unlabeled data from health examination data. Although
SHG-Health is conservative in predicting cases into high-risk classes, we have shown that it was
able to predict the correct disease classes with high scores in all evaluation measures. This is very
desirable for the preventative type of Clinical Decision Support Systems (CDSSs). False positives are
especially costly in preventive care, which could result in unnecessary anxiety, worry, and invasive
diagnostic tests [86, 63]. In addition, it is believed that CDSSs are to support clinical professionals
rather than to replace them. Therefore, a good system should be able to identify and draw attention
to participants with high risks.
5.5 Summary
Mining health examination data is challenging especially due to its heterogeneity, intrinsic noise
and particularly the large volume of unlabeled data. In this chapter, we introduced an effective and
efficient graph-based semi-supervised algorithm namely SHG-Health to meet these challenges.
Our proposed graph-based classification approach on mining health examination records has a
few significant advantages over existing approaches.
• Firstly, medical examination records are represented as a graph that associates all relevant cases
together. This is especially useful for modeling abnormal health examination results that are
often sparse.
• Secondly, multi-typed relationships of data items can be captured and naturally mapped into a
heterogeneous graph. Particularly, the medical examination items are represented as different
types of nodes on a graph, which enables our method to exploit the underlying heterogeneous
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subgraph structure of individual classes to achieve higher performance.
• Thirdly, features can be weighted in their own type through a label propagation process on a
heterogeneous graph. These in-class weighted features then contribute to the effective classifi-
cation in an iterative convergence process.
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Chapter 6
Drug Recommendations from Medical
Literature
In the previous chapters, we focused on classification problems for health risk/score prediction based
on real healthcare datasets. In this chapter, we turn to explore another useful data source, namely
medical literature. In particular, we look at a drug recommendation problem based on the MEDLINE
medical literature dataset. This research was conducted based on a collaboration with The Third
Xiangya Hospital, Changsha, China.
6.1 Problems and Challenges
In the age of information explosion, big data has the potential to improve clinical decision-making and
revolutionize research [76]. The past decade has witnessed a dramatic growth of electronic biomedical
literature, which is generated and stored in digital form and provides a substantial amount of reliable
data that forms a rich source for Evidence-Based Medicine (EBM) research. However, it is no longer
possible to process all the information available manually in order to keep clinical knowledge up to
date.
To cope with this challenge, on the one hand, methods have been developed to improve document
retrieval from biomedical literature databases [78, 136, 54, 13]. On the other hand, text mining tech-
niques have been developed for extracting useful information from biomedical literature databases
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[32, 114, 72, 70, 59] such as the MEDLINE database [3], a bibliographic database of life science lit-
erature, maintained by the U.S. National Library of Medicine. A comprehensive review on literature-
based discovery for novel therapeutic approaches can be found in [59].
In this chapter, we focus on a drug recommendation problem based on the MEDLINE database. In
particular, we deal with an antihypertensive drug recommendation problem for chronic kidney disease
patients. We approached the problem with a graph-based data mining algorithm. Specifically, our
method constructs a heterogeneous graph by extracting objects of different types from the MEDLINE
medical literature database. We adapted our previously developed graph-based ranking algorithm
MedRank [20] to utilize link structure of a heterogeneous graph for drug recommendation.
The rest of the chapter has been organized as follows. Section 6.2 gives the background of the
Chronic Kidney Disease and literature-based EBM. Section 6.3 describes our methodology, including
data sources, graph construction, and the ranking mechanism on the extracted heterogeneous graph.
In Section 6.4, we evaluated the system recommended results with expert opinions collected via a
questionnaire. Section 6.5 concludes our work in this chapter.
6.2 Background
Chronic kidney disease (CKD) is a worldwide public health problem that affects millions of people
from all racial and ethnic groups [77]. In China, for example, the morbidity of CKD was approxi-
mately 10.8%, and its prevalence was estimated to be 119.5 million [139]. Hypertension is a major
risk factor for the progression of CKD. It was reported to be present in 36% to 84.1% of patients with
CKD [119] and contributed to progression toward End-Stage Renal Disease (ESRD) and cardiovas-
cular events [101, 118]. However, the rate of blood pressure (BP) control was extremely low. Only
11% of patients reached their target goals [31] and the rate was even lower in developing countries
[115].
In the era of Evidence-Based Medicine (EBM), medical decision-making is often optimized by
emphasizing the use of evidence from well-designed and well-conducted studies. Although EBM
helps physicians make decisions for medical care, in clinical practice, it suffers from possible abso-
lutisation of the evidence obtained from Randomized Controlled Trial (RCT) and overestimating the
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generalisability of the evidence [142]. Random sampling has been a highly successful mainstream
method of clinical medical research. However, its accuracy depends on ensuring randomness, which
is costly and difficult. Moreover, evidence-based clinical decision support does not adequately ad-
dress the complexity of care and can be soon out of date.
These limitations of EBM have motivated us to develop an antihypertensive drug recommendation
data mining application for CKD patients with hypertension.
6.3 The Methodology
To approach the problem of evidence-based antihypertensive drug recommendation for patients with
CKD, we constructed a heterogeneous graph from the MEDLINE database and adapted a graph-
based ranking algorithm called MedRank [20] to rank objects on the graph. Particularly, we ranked
the antihypertensive drugs specified by our medical experts. MedRank is a graph-based algorithm
that ranks objects (such as journal articles, diseases, treatments, authors, journals, etc.) in terms of
referential relationships expressed as a heterogeneous graph. It was originally proposed to utilize
linkage information among data objects to rank influential treatments for a given disease based on
a medical information network. In this study, MedRank has been adapted to rank antihypertensive
drugs on a heterogeneous graph extracted from a medical literature database.
In this section, we first introduce the data sources of this study, namely the MEDLINE [3] med-
ical literature database and the MeSH [4] ontology that MEDLINE uses to index articles. Then we
describe the process of extracting a heterogeneous graph from the MEDLINE database. Finally, we
introduce our graph-based ranking method that ranks the extracted heterogeneous graph for drug rec-
ommendation.
6.3.1 Data Sources
MEDLINE and MeSH
The biomedical literature database employed in this study is the MEDLINE database [3]. It consists
of more than 23 million journal citations and abstracts. The database is maintained by the National
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Library of Medicine (NLM) and is indexed by the NLM Medical Subject Headings (MeSH) [4].
MeSH is a hierarchically structured medical thesaurus and controlled semantic vocabulary that
is a part of the larger Unified Medical Language System (UMLS) thesaurus of the NLM. There are
27,883 descriptors more than 232,000 Supplementary Concept Records (SCRs) that provide formal
and explicit specifications of the present biomedical concepts. The descriptors are arranged both
alphabetically and hierarchically as a tree structure.
MEDLINE corpus can be acquired in XML format. Each citation contains the bibliographical
information of an article, such as the article ID (PMID), article title, author list, journal title, venue,
publication type, and indexed MeSH terms. MEDLINE is used as a surrogate for full-text articles.
Permission to access the data in this study was acquired by The Third Xiangya Hospital in China in
June 2015.
6.3.2 MEDLINE Article Selection Criteria
The MEDLINE articles considered in this study were studies on human hypertension combined with
CKD. We used the MeSH headings indexed in MEDLINE to select these articles. The following four
categories of selection criteria must be satisfied for an article to be qualified.
Human Criteria
• The indexed MeSH terms of an article must include “Humans”.
Disease Criteria
• The indexed MeSH terms of an article must include “Hypertension”.
• The indexed MeSH terms of an article must include either “Kidney Failure” or “Renal Insuffi-
ciency, Chronic”.
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Drug Criteria
The antihypertensive drugs considered in this study belong to eight major categories of antihyperten-
sive drugs, namely, diuretics, adrenergic α−antagonists, adrenergic β−antagonists, angiotensin con-
verting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers
(CCBs), vasodilator agents, and ganglionic blockers.
Articles on these antihypertensive drugs can be identified via the indexed MeSH terms. The MeSH
terms for antihypertensive drugs that belong to the eight major categories include 95 heading terms
and 121 supplementary concepts. To build a model for treatment recommendations, only the articles
indexed by the above MeSH terms for antihypertensive drugs that were labeled with the qualifiers
“therapeutic use”, “drug therapy”, or “administration & dosage” were extracted for modeling.
Publication Type Criteria
The publication type and publication date information of the articles were extracted for the purpose
of article selection. The publication types under consideration include any of the following indexed
MeSH terms: “meta-analysis”, “randomized controlled trial”, “pragmatic clinical trial”, “twin study”,
“controlled clinical trial”, “observational study”, “comparative study”, and “case report”. We also
extracted the publication year from the publication data information of the articles to indicate their
recency.
6.3.3 Heterogeneous Graph Extraction
We constructed a weighted heterogeneous graph of five types of objects extracted from the MEDLINE
corpus. These five object types are Article, Author, Journal, Publication Type, and Antihypertensive
Drug. Every MEDLINE citation record that satisfied the “human” and “hypertension” selection crite-
ria was modeled as an instance of the Article type object on the graph. The authors, publishing journal,
publication type, and antihypertensive drugs associated with an article were modeled as instances of
the Author, Journal, Publication Type, and Antihypertensive Drug types of objects respectively, with
an edge to the Article object on the graph. The edge weight of each edge in the graph was calculated
based on the following four factors:
118 DRUG RECOMMENDATIONS FROM MEDICAL LITERATURE
FIGURE 6.1: The schema extracted from the MEDLINE database.
• Time factor (T): The publication year of an article was extracted as the time information about
the article. If the article was published in the current year, the weight = 0; if it was published in
the past 10 years, the weight = 1; otherwise, the weight = -1.
• Publication type (P): Articles that report a meta-analysis or Randomized Controlled Trial
(RCT), the weight = 1; otherwise, the weight = 0.
• Design methods of clinical trials (D): If an article was indexed by random allocation, multi-
center studies, double-blind method, and single-blind method, the weight = 1; otherwise, the
weight = 0.
• Institutions and funding sources (I): If the article was indexed by “Financing, Government”,
“Academies and Institutes”, “Government”, and “Organizations, Nonprofit”, weight = 1; other-
wise, weight = 0.
The final weight of a link is calculated by the function: 0.6+(T+P+D+I)/10.
6.3.4 Ranking on a Heterogeneous Graph
We adapted the MedRank algorithm [20] to rank the objects on the extracted heterogeneous graph. We
then extracted a heterogeneous graph for our drug recommendation problem. As Figure 6.1 shows,
the graph has a star-shaped schema, containing five object types, namely, the Article, Author, Journal,
Publication Type, and Antihypertensive Drug object types, with Article as the center type.
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In order to find the most influential drugs, all associated objects had to be considered. The rea-
soning behind the algorithm was as follows.
• A drug is “influential” if it is mentioned by many good articles, published with clinical trials
that have positive results;
• An article is good if it is written by reputed authors and published in a good venue;
• A good venue is one that has a high impact on research; and
• An author is reputed if they have published many good articles.
At first glance, these definitions of “goodness” may seem to be circular. However, the algorithm is
able to identify the listed above altogether by finding highly connected multi-objects on the graph.
The algorithm computes the ranks of objects of the same type based on the link relationship
amongst objects of different types on the heterogeneous graph. It iteratively updates the ranks until
convergence occurs using the following updating function Eq. (6.1) below:
R
〈h+1〉
X1
← (α(
n−1∏
t=1
WXtCD
−1
CXt+1
WCXt+1)WXnCD
−1
CX1
WCX1 + (1− α)U/|X1|)R〈h〉X1 (6.1)
where type index t ∈ {1, ..., n − 1} and n is a positive integer greater than 1 indicating the total
number of types; Xt denotes the tth object type and X1 is the target type, i.e., the antihypertensive
drug in our case; RX1 is a vector for the rank of X1 type objects; C is the center type, i.e., the Article
in our case; U is an |X1| × |X1| unit matrix and |X1| denotes the total number of objects of type X1;
α is known as a damping factor that determines the ratio of the impact from the previous iteration
and that from the global rank which is calculated uniformly as U/|X1|; WAB is a weighted adjacency
matrix of type A and type B objects, storing the weighted links between them; D−1AB is a diagonal
matrix with diagonal value equivalent to the row sum of WAB for the purpose of row-normalization.
Mathematically, the algorithm can be seen as a random walk on a heterogeneous graph. The ran-
dom walker decides which neighboring node to visit next based on the probabilities expressed as the
link weights. Also the random walker might restart a new walk based on the probabilities controlled
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Algorithm 4 Drug Recommendation Algorithm
Input: a set D of medical articles and a set of selecting criteria S.
Output: a vector R〈∗〉X1 of the stationary ranks of the target type X1 objects.
1: Ds ← select articles from D based on the selection criteria S.
2: W ← graph construction from Ds (Section 6.3.3).
3: Initialize RX1 uniformly for type X1 objects.
4: h = 1
5: repeat
6: Update R〈h〉X1 by:
7: R
〈h+1〉
X1
← (α(∏n−1t=1 WXtCD−1CXt+1WCXt+1)WXnCD−1CX1WCX1 + (1− α)U/|X1|)R〈h〉X1 (6.1)
8: h = h+ 1
9: until convergence return R〈∗〉X1
by the damping factors. The algorithm updates the probabilities of the links in each iteration. It ter-
minates when it reaches stable probabilities, i.e., a stationary vector R〈∗〉X1 . This type of algorithms
is able to discover highly connected regions of nodes in a graph. An object will be ranked high if
its connected objects are also ranked high, which realizes the idea that a good article is written by
good authors, published by a reputed venue, etc. The output of the algorithm is the ranking of the
Antihypertensive Drug objects in its own type. The overview of our drug recommendation algorithm
is summarized in Algorithm 4.
6.4 Experiments and Evaluation
A total of 4,304 papers, 13,325 authors, and 931 journals were extracted from the MEDLINE dataset
based on the selection criteria described in the previous section for the experiment. These papers were
published between 1965 and 2015 and included 420 comparative studies and 204 RCTs.
6.4.1 Settings
To compare the ranking differences in antihypertensive drugs over time, we extracted sub-graphs
based on the ranges of publication year. The ranges (≤ 1977,≤ 1980,≤ 1984,≤ 1988,≤ 1993,≤
1998,≤ 2003,≤ 2013) were selected according to the years indicated by the authoritative hyperten-
sion guidelines from the Joint National Committee (JNC) [17, 26, 48, 10, 27, 100]. The statistics of
the articles in the corresponding JNC indicated years is shown in Table 6.1.
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6.4.2 Questionnaire Design
A web-based questionnaire was designed for validating the ranked antihypertensive drug list by the
proposed model. A survey was conducted according to the Declaration of Helsinki and was approved
by the Medical Ethics Committee of the 3rd Xiangya Hospital (no. 2015-S169). The questionnaire
was anonymous and the confidentiality of the demographic and personal data of each physician in-
cluded in the survey was carefully preserved and strictly protected during each phase of the study.
Main Purpose
The main body of the questionnaire consisted of 22 single-choice or multiple-choice questions. The
main purposes of the survey questionnaire were as follows:
• to collect the basic information of physicians, such as location, level of hospital, department,
whether outpatient service was provided in the previous three months, position title, age, gender,
and whether the hypertension guidelines were used (Questions 01 to 09);
• to obtain the physicians’ preferences for antihypertensive prescriptions for hypertensive patients
complicated with either CKD or diabetes (Questions 10 to 12 and 15 to 17). Physicians were
asked to choose their first, second, and third preferences for the type and the name of antihyper-
tensive drugs from a pre-specified list. Information regarding antihypertensive drugs is largely
based on the MeSH terms; and
TABLE 6.1: Statistics over the years.
Papers Authors Journals
1977 0 0 0
1980 0 0 0
1984 21 57 19
1988 165 553 101
1993 601 1,724 217
1997 1,017 3,044 313
2003 2,298 6,413 556
2013 5,363 17,399 1,144
2015 5,424 17,632 1,152
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• to investigate physicians’ preferences for optimal BP targets and their strategy of antihyper-
tensive drug combinations when managing hypertensive patients with either CKD or diabetes
(Questions 13 to 14 and 18 to 22).
Another aim of the survey was to analyze the concordance among the physicians included in
the survey and to stratify the results according to area, age, gender, department, hospital level, and
position of the physician (resident, attending, associate chief, or chief).
Sample Size
The following formula was used for calculating the sample size of physicians enrolled in the study:
N = 2 ∗ z/(d2 ∗ p ∗ q)
where z is the risk of Type I error, d is the absolute precision, p is the expected prevalence, and q=1-p.
Using a 95% confidence interval (95% CI), 80% power, an estimated precision of 5%, and assuming
the concordance rate between the system and physician rankings to be 65.8% according to [20], the
estimated sample size was 168.
Survey Distribution
The survey was sent to members of the China Hypertension Alliance by email or WeChat Version
4.0 (WeChat, Tencent) using a snowball-sampling strategy. Recruitment of physicians occurred be-
tween October 2015 and November 2015. The participants involved in this survey included both gen-
eral practitioners and specialized physicians operating in different clinical settings (outpatient clinics
and/or in-hospital divisions), geographical locations (both north and south of China), and different
clinical activities so that we could obtain a representative sample of physicians with experience in
patients with hypertension in China. The participants did not receive any remuneration for taking part
in the survey.
6.4 EXPERIMENTS AND EVALUATION 123
6.4.3 Evaluation Measures
All analyses were performed using IBM SPSS Version 22.0 (SPSS, Inc., Chicago, IL). The present
analysis was limited to the answers provided in the main body of the survey questionnaire. Continuous
variables were presented as the means±standard deviations (SDs) or as medians and interquartile
ranges (IQRs) when the data exhibited a skewed distribution. Analysis of variance (ANOVA) or a
post hoc analysis of the least significant difference (LSD) was used to compare the means of normally
distributed continuous variables; otherwise, the Kruskal-Wallis test was used. Categorical variables
were expressed as proportions and tested using the chi-square test. A P-value of 0.05 (two-tailed) was
established as the threshold for statistical significance.
To compare the consistency between the preferences of physicians and the ranking results, the
average overlap (AO)[38] measure was used. The AO is a measure of the concordance between two
ordered lists that may not have equal lengths. It computes the weighted average of the overlap of the
first d elements in both lists, with the weight decreasing as d increases. In other words, the overlaps
that occur at the top of the list are counted as more important than are those at the end. The AO score
is in the range of [0,1] inclusive, where 0 indicates no items shared by the two lists and 1 indicates
that the two lists are identical. The formula is shown in Eq. (6.2).
AO(S, T,K) =
1
K
K∑
d=1
|S:d ∩ T:d|
d
(6.2)
where K is the top-K ranked items of interest; S and T are two ranking lists; S:d denotes the set of
elements in S from the first up to the dth position; T:d is defined in the same way as S:d.
6.4.4 Results
According to the recommendations of our model, the top ranked categories of first-line antihyperten-
sive drugs are ordered as follows: ARB, ACEI, CCB, diuretics, adrenergic -antagonists, vasodilator
agents, ganglionic blockers, and adrenergic -antagonists. The top 10 ranked individual antihyperten-
sive drugs for patients with CKD are reported in Table 6.2 with Irbesartan at the top. Although only
six drugs that belong to RAS inhibitors in the table were consistent with the latest guidelines, the other
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TABLE 6.2: Top 10 ranked hypertensive drugs.
Top K Drug Ranking # of supported studies
1 Irbesartan 0.151 26
2 Ramipril 0.138 11
3 Benazepril 0.087 6
4 Losartan 0.08 17
5 Captopril 0.061 27
6 Amlodipine 0.058 12
7 Enalapril 0.049 20
8 Furosemide 0.048 39
9 Nitrendipine 0.041 3
10 Atenolol 0.041 10
kinds of drugs (adrenergic β-antagonists, diuretics, and CCB) were also used as first-line antihyper-
tensive agents when there were contraindications to RAS inhibitors or used as drug combinations in
CKD patients.
Note that the numbers in the ranking column in Table 6.2 are the limiting probabilities, so that the
sum of ranks for all drug object in the extracted graph is equal to 1. As a result, the larger the number
of antihypertensive drugs considered in the model, the smaller the ranking score for individual drugs.
The number of citations that support the antihypertensive drugs Irbesartan, Ramipril, and Be-
nazepril were found to be 26, 11, and 6, respectively. Although the citation number contributed to the
ranking, it was not a decisive factor.
Table 6.3 illustrates the top 5 ranked results of four year ranges. This can be compared against
Table 6.4 where the recommendations from the hypertension guidelines of the Joint National Com-
mittee (JNC) [17, 26, 48, 10, 27, 100] are given. The top recommended antihypertensive drug by
our method calculated from studies performed before 1980 was Furosemide, a type of loop diuretic,
which was matched the recommendations by JNC 1 (1976) and JNC 2 (1980). The introduction of
Adrenergic-inhibiting agents and ACEI in the JNC 3 (1984) guildline could explain the rising uses of
these two types of drug, which was also reflected in the top 2 to 4 drugs by our method.
According to our model, loop diuretics became less important over time, and the importance of
ARBs increased rapidly. In 1993, ACEIs became the top antihypertensive drugs in our model. But by
2013, ARBs became more influential than ACEIs and became the leading drugs. However, the JNC
5 [48], still emphasized the importance of loop diuretics in 1993. ACEIs were recommended by the
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TABLE 6.3: Top 5 ranked hypertensive drugs (name,category) in year ranges.
Year Range Top K Drug Name
<1980
1 Furosemide, loop diuretic
2 Captopril, ACEI
3 Prazosin, adrenergic-inhibiting agents
4 Labetalol, adrenergic-inhibiting agents
5 Minoxidil, vasodilators
<1993
1 Captopril, ACEI
2 Nitrendipine, CCB
3 Furosemide, loop diuretics
4 Enalapril, ACEI
5 Minoxidil, vasodilators
<2003
1 Captopril, ACEI
2 Nitrendipine, CCB
3 Losartan, ARB
4 Enalapril, ACEI
5 Ramipril, ACEI
<2015
1 Irbesartan, ARB
2 Ramipril, ACEI
3 Benazepril, ACEI
4 Losartan, ARB
5 Captopril, ACEI
JNC 6 as the first-line drug for patients with CKD until 1998 [10]. Figure 6.2 shows the changes of
ranking order of antihypertensive drug categories over the years computed by our model.
Overall, 377 physicians (174 males, mean age 35.65±9.89 years) were included in this present
study, and all completed the survey, including 49.34% who had regularly treated outpatients in the
previous three months. The vast majority of clinicians were cardiologists (206, 54.64%), followed
by specialists in general medicine (23, 6.1%), nephrology (23, 6.1%), and surgery (20, 5.31%). The
distribution of physicians nationally was substantially homogeneous. A total of 59.63% of physicians
were active in Southern China, and 40.37% were active in Northern China. Most (76.92%) worked
at tertiary hospitals. According to this web survey, 44.30% (167/377) of physicians preferred to
prescribe ACEIs as their first choice for patients with CKD, whereas only 28.12% (106/377) chose
CCBs, and 25.73% (97/377) chose ARBs. Generally, the concordance between system ranking and
physician ranking was not high (AO, 0.53±0.20). Interestingly, as the position of a drug increased
on the list, the concordance increased, as shown in Figure 6.3. However, the AO scores did not
significantly differ according to area, age, gender, department, and hospital level.
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TABLE 6.4: Guidelines from the Joint National Committee (JNC)
Version Year Quotes
JNC 1 1976 ‘Furosemide is not usually a step 1 drug but is especially
useful in renal insufficiency or resistance cases’.
JNC 2 1980 No change
JNC 3 1984 ‘loop diuretics are effective in chronic kidney failure’;
‘Adrenergic-inhibiting agents, vasodilators, ACEIs are usu-
ally effective in patients with renal disease’
JNC 4 1988 ‘loop diuretics are effective in chronic kidney failure’; ‘Re-
cent studies, particularly in diabetic nephropathy, suggest
that the use of ACE Inhibitors may possess specific advan-
tages in decreasing proteinuria and slowing the progression
of renal failure’.
JNC 5 1992 ‘Higher doses of loop diuretics may be needed for patients
with renal impairment’; ‘A loop diuretic or metolazone or
indapamide is usually necessary or accomplishes substan-
tial diuresis when the serum creatinine level has reached
221 mol/l or more’.
JNC 6 1997 ‘...patients with hypertension who have renal insufficiency
should receive, unless contraindicated, an ACE Inhibitor (in
most cases, along with a diuretic) to control hypertension
and to slow progressive renal failure’.
JNC 7 2003 ‘The ACE inhibitors and ARBs have demonstrated favor-
able effects on the progression of diabetic and non-diabetic
renal disease’.
JNC 8 2013 ‘In the population aged 18 years of age or older with CKD,
initial (or add-on) antihypertensive treatment should include
an ACEI or ARB to improve kidney outcomes. This applies
to all CKD patients with hypertension regardless of race or
diabetes status. (Moderate Recommendation Grade B)’.
6.5 Summary
In this chapter we demonstrated that drug recommendations based on medical literature can be com-
puted based on the graph-based ranking algorithm that we proposed. Particularly, we verified our
approach by evaluating our model recommended drug list against expert preference of antihyperten-
sive drug prescription for CKD patients. The AO scores (Figure 6.3) showed that our recommen-
dations were not only promising but had a high concordance with the preferences of the physicians
with higher ranks. In addition we computed drug recommendations based on articles published in
different year ranges and compared the results against the JNC guidelines. We also showed that our
model recommendations matched several key changes of the JNC guidelines (Figure 6.2 and Table
6.4).
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FIGURE 6.2: Comparison of the Top 10 ranked antihypertensive drug categories over years.
FIGURE 6.3: Average Overlap scores in terms of physicians’ position level.
Our study opens up a new direction of evidence based decision support that combines the follow-
ing features.
• The proposed literature-based data mining method is able to recommend antihypertensive drug
categories prior to the release of hypertension guidelines.
• It recommends the most influential treatment for a given disease, which is specific to drug
names, accounting for evidence level and time.
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Chapter 7
Conclusion and Future Work
7.1 Conclusions
This thesis has been driven by the practical need for mining healthcare data from large and multiple
data sources. Particularly, we focused on developing effective classification models for healthcare
applications, tackling issues identified from real healthcare datasets. The main objectives have been
successfully achieved. Specifically, we have accomplished three tasks:
• We identified problems and challenges in learning classification models for healthcare applica-
tions, namely feature extraction, label uncertainty, and large unlabeled data issues.
• To address these problems, we developed algorithms that were able to deal with those issues.
• We evaluated the proposed approaches with real-world health examination datasets and syn-
thetic datasets.
In Chapter 1, we introduced the research motivation and background of healthcare data mining
with an emphasis on health risk prediction, including the scope of the field and definition of Electronic
Health Records (EHRs). In particular, we specified the main datasets that this research was based on
in the background section, identified their characteristics, and gave a formal definition of General
Health Examination (GHE) record sequence. Finally, we presented research challenges, goals, and
the main contributions of this thesis.
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In Chapter 2, we presented a brief literature review on the research topics that are related to our
research. We divided the literature review into three sections. In the first section, we reviewed the
traditional data analysis approaches in the medical literature. Particularly, we paid attention to the
existing data analytics type work on health examination records as well as the studies on health scor-
ing systems that are often used in critical care. In the second section, we reviewed the literature on
mining healthcare data with an emphasis on classification problems, summarising existing studies
on classification-based risk prediction. We also reviewed existing approaches to handling label un-
certainty and large unlabeled data for healthcare applications. In the concluding section, we briefly
reviewed the related work on text mining of medical literature.
In Chapter 3, we proposed a classification-based framework based on a large General Health
Examination (GHE) dataset for overall health score prediction based on mortality labels. We called
this predicted score “Personal Health Index” (PHI), which is defined as the complement probability
of health risk. Our framework contained the following four stages:
• Pre-processing was performed to clean the raw data and transform the numerical, ordinal, and
categorical features into binary representation.
• We then proposed two representation strategies for modeling record sequence were proposed.
Particularly, we used time smoothing functions to merge record sequence into a feature vector.
Our approach is capable of handling the time dimension of record sequence.
• With this we trained SVM classification models with different kernels and conducted feature
selection.
• Finally, our framework was evaluated based on a real General Health Examination (GHE)
dataset (Section 1.2.1). The experiments showed that the proposed PHI prediction framework
could effectively predict PHI and identify high health risk participants.
In Chapter 4, we extended the PHI prediction framework described in Chapter 3 from an overall
health score to a vector of k predicted scores in the range of [0, 1] interval, reflecting personal health
risks in k disease categories. This led us to use the main Cause of Death (COD) information as labels.
However, due to the possible comorbidity, the COD label may not be 100% certain.
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To tackle this classification problem with label uncertainty, our prediction framework contains
four steps.
• Data pre-processing was conducted as in Chapter 3.
• We then extracted features based on a Chi-Square time smoothing function to handle the time
aspect of record sequence.
• With this we proposed a soft-label learning approach that learns from target examples, related
examples, and negative examples. In our case, these are the examples of the target disease, of
the non-target diseases, and of the alive cases respectively.
We evaluated the proposed method on the same GHE dataset of 102,258 patients (Chapter 1.2.1).
The experimental results demonstrated the effectiveness of our algorithm.
In Chapter 5, we tackled the large unlabeled data issue identify from our GHE dataset with linked
COD labels. In fact only 7.4% of GHE participants have a COD label. The risk prediction problem
was formulated as a multi-class classification problem with large unlabeled data. We proposed a
graph-based semi-supervised algorithm called SHG-Health to solve the problem.
Two key steps are involved in our approach.
• A heterogeneous graph is constructed based on the GHE dataset. Specifically, four types of
nodes were extracted, namely, Record, Physical Test, Mental Test, and Profile. In addition, the
links between nodes were weighted according to the time of the examination took place.
• We proposed an efficient semi-supervised algorithm to iteratively learned the model based on
the extracted heterogeneous graph.
Our approach has the following two advantages.
• It is capable of capturing the heterogeneous nature of GHE data.
• It has a mechanism to learn an additional “unknown” class based on the heterogeneous graph
structure.
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The proposed algorithm was evaluated using our GHE dataset as well as synthetic datasets. The
experimental results showed that our method can effectively handle large unlabeled data and that it
enjoyed a superior performance over baseline methods and other graph-based algorithms compared.
In Chapter 6, we turned to explore another data source, namely a biomedical literature database
called MEDLINE. Specifically, we tackled the problem of antihypertensive drug recommendations
for Chronic Kidney Disease (CKD) patients based on MEDLINE biomedical literature. Our approach
contains two steps.
• We extracted from MEDLINE different types of objects via the indexed MeSH terms to con-
struct a heterogeneous graph.
• We then adapted a graph-based algorithm to rank the drug objects on the graph for drug recom-
mendation.
Our system was evaluated based on the expert opinions collected via questionnaire. The results
showed that our system recommendations had a high concordance with expert preferences collected
via a online questionnaire.
7.2 Future Directions
Overall, we believe that this research has provided a new direction of quantifying personal health
through data mining techniques. We propose two possible directions for future investigation.
7.2.1 Data Fusion for Personalized Healthcare
Accurate, personalised, and cost-effective healthcare is the vision of the future. We believe that can
be possible from cradle to grave, through trends and predictions derived from mining large real health
datasets. Our research had its main focus on real health examination data and we also investigated
the use of biomedical literature. Other information sources, such as online medical information, bio-
marks collected from mobile sensor devices (e.g., accelerometer and gyroscope on a smart phone
recording the daily activities of a person), and in-hospital data, could be linked to obtain more com-
prehensive results. Skillful mining of such a fusion of data could well make the vision a reality.
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7.2.2 Feature Extraction for Longitudinal Data
Health records stored according to date/time order form a time-series of records. Each record in the
series may contain a large number of measurements. One big challenge of healthcare data mining is
extracting important information from the high dimensional time-series for modeling. In our research,
we had considered time smoothing functions to transform record sequence into a feature vector. We
also used graph representation with time-weighted edges. However, how to extract features that are
able to capture changes in high dimensional measurements over time is still an open problem. A
systematic study on the effects of different representational approaches should be beneficial to this
area of research.
7.3 Personal Reflection
My journey of completing this PhD study has been a journey full of the excitement of discovery,
though sometimes with ups and downs. Developing classification models to improve clinical decision
support is a research direction which I personally found especially significant because of its direct
applications to healthcare.
I derived greatest satisfaction from knowing that we were working with real data of real peo-
ple, knowing this would enable doctors to make more accurate, personalised, and efficient clinical
judgements. It was not academic.
Perhaps the lowest point was the three-month period of data pre-processing at the beginning. It
was full of uncertainties regarding whether the quality of the data would be good enough for sensible
data mining, what assumptions would be reasonable for handling different features, and to what extent
we might gain support from medical professionals. The tedious nature of the pre-processing often
made me wonder if this was worthwhile at all. Now I can say, yes, by all means. The more one
understands the data, the more they would be able to understand why when a model did not work and
to come up with ideas that might work.
In this journey, the more I dug into the problem the more avenues of exploration opened up before
me. At times I felt like I was only just scratching the surface. It is my humble hope that what we have
done here will form a foundation from which others can go further.
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